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ABSTRACT

Post Intensive Care Syndrome-Family (PICS-F) refers to acute and chronic psychological
effects of critical illness on family members of patients in intensive care units (ICU). Evidence
about the increase and persistence of PICS-F warrants the need for prevention interventions. This
study evaluated the feasibility of providing Sensation Awareness Focused Training (SĀF-T)
during the ICU stay for spouses of mechanically ventilated patients. Methods: A randomized
controlled trial of SĀF-T versus a control group was conducted (n=10) to assess safety,
acceptability, feasibility, and effect size of the intervention on PICS-F symptoms. Symptoms
assessed as outcome measures included stress, anxiety, depression, posttraumatic stress disorder,
and sleep efficiency. Those randomly assigned to SĀF-T received one session daily over 3-days
in the ICU. Repeated measures (day 1, day 3, day 30, and day 90) of PICS-F symptoms in both
groups were analyzed. Results: Mean age was 58 ± 12 years; 70% were female. Feasibility
success criteria were met in weekly recruitment (8 ± 3.5), enrollment rate (67%), SĀF-T
acceptability (100% of doses received, no adverse events) with significantly lower post SĀF-T
stress levels (p<.05) compared to pre SĀF-T stress levels, ActiWatch acceptability rate (90%
agreed to wear, no adverse events) with no significant difference in sleep efficiency between
groups (p>.05), and repeated measures completion rate (>90%). Conclusions: This study
provided guidance for modifications to protocol outcome measures and evidence of a large effect
size, which will inform a larger clinical trial to assess the effectiveness of the SĀF-T intervention
in reducing PICS-F.

viii

CHAPTER ONE:
BACKGROUND

Post Intensive Care Syndrome
More than 5.7 million patients are admitted to intensive care units (ICU) each year in the
United States (Society of Critical Care Medicine [SCCM], 2015). Surviving critical illness is a
turning point in the lives of patients (ICU survivors) and their families. SCCM (2013) identified
a cluster of complications from experiencing critical care that occur in both ICU survivors and
their family members, as Post Intensive Care Syndrome (PICS) with an added “F” to represent
presence in family (PICS-F). PICS is defined as new or worsening impairment in physical (ICUacquired neuromuscular weakness), cognitive (thinking and judgement), or mental health status
arising after critical illness and persisting beyond discharge from the acute care setting. PICS-F
refers to acute and chronic psychological effects of critical illness on family members of the
patient and includes symptoms that are experienced by family members during the critical
illness, as well as those that occur following ICU discharge or death of a loved one in the ICU
(Rawal et al., 2017). In the context of the study, family is defined by the patient, as related or
unrelated individuals who provide support and with whom the patient has a significant
relationship (Davidson et al., 2017). Spouse is defined by the patient as the individual with
whom the patient has a significant intimate relationship.
PICS conditions convey substantial burden including decreased quality of life and
significant physical, cognitive, and psychological impairment. Specifically, PICS conditions
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include ICU-acquired weakness; problems with executive function, memory, and attention;
ongoing anxiety, depression, and posttraumatic stress disorder (PTSD). These symptoms may
occur in a variety of combinations. Furthermore, Figure 1 exhibits how PICS conditions vary
among ICU survivors and their family members.
Post Intensive Care Syndrome

ICU Survivor

Physical
Impairment:
• ICU
Acquired
Weakness

Cognitive
Impairment:
• Executive
Function
• Memory
• Attention

Family Member

Psychological Impairment:
• Anxiety
• Depression
• Posttraumatic Stress Disorder

Psychological Impairment:
• Acute Stress Disorder
• Anxiety
• Depression
• Posttraumatic Stress Disorder
• Complicated Grief

Decreased Quality of Life:
• Lack of Physical Energy
• Lack of Sleep
• Lack of Appetite
• Lack of Self-Care
• Change in Family Role and
Responsibilities
• Delayed Life Plans
• Family Conflicts
• Social Stigmatization

Decreased Quality of Life

Figure 1. Post Intensive Care Syndrome (PICS) Model in ICU survivors and family members.
PICS physical and cognitive impairments are prevalent among ICU survivors as critical
illness sequelae. PICS psychological impairments are prevalent in both ICU survivors and their
family members (PICS-F) suggesting an association with the ICU experience. Psychological
impairment is greater and persists longer in family members than in ICU survivors (Fumis,
Ranzani, Martins, & Schettino, 2015). One rationale for greater prevalence in family members is
that they are acutely aware of and witnessing the events their loved one is going through with a
sense of forced helplessness. A rationale for longer persistence is that many family members
2

experience the incumbrance of informal caregiver for long road of recovery for the ICU survivor,
which can have physiological and social consequences (i.e., lack of physical energy, lack of
sleep, lack of appetite, lack of self-care, change in family role and responsibilities, delayed life
plans, family conflicts, and social stigmatization). PICS is now being recognized as a public
health burden due to the associated neuropsychological and functional disability, however, the
psychological impact on family members (PICS-F) are usually under-recognized and
interventions targeted on symptoms of PICS-F are lacking.
Post Intensive Care Syndrome-Family
Family members suffer a great deal when a loved one is admitted to the ICU. Inside the
crowded, beeping, blinking, alarming ICU room, normal sleep is disrupted. Sleep disturbances
are reported as one of the top stressors during the ICU stay by family members (Netzer &
Sullivan, 2014; Novaes et al., 1999; Verceles et al., 2014). Since many ICU patients are not
cognitively intact as a result of acute illness and accompanying medical treatments, family
members of ICU patients are often asked to make health decisions for their loved one. Family
members in the role of surrogate health decision-maker are often burdened with the
responsibility of making the “right” decisions for patients. The uncertainty and life-threatening
nature of critical illness, combined with the burden of surrogate health decision-making and the
added stress of sleep disturbances elicit a state of psychological distress in family members
during the ICU stay. Increased distress in family members during the ICU stay may increase risk
of PICS-F.
The psychological impact of PICS-F in family members include ongoing stress, anxiety,
depression, and posttraumatic stress disorder (PTSD). Pochard et al. (2005) reported spouses of
critically ill patients were more likely to suffer from depressive symptoms compared to all other
3

family members. The researchers confirmed that symptoms of anxiety and depression were
found in 73.4% of spouses and 35.3 % of family members respectively. These results are
consistent with other researchers indicating that as many as two thirds of family members have
symptoms of anxiety while the patient is in the ICU (Azoulay et al., 2005). In addition to
depression and anxiety, Paparrigopoulos and colleagues (2006) reported that during the first
week of critical illness, a majority (81%) of family members had a quantity of symptoms which
placed them at risk for PTSD. Azoulay and colleagues (2005) reported more than a third of
family members are at risk for PTSD at three months. Anderson and colleagues (2008) found
that almost half (49%) of family members reported PTSD six months after the ICU survivors’
hospital discharge.

Problem Statement
Critical illness is a family crisis. Spouses of critically ill patients are often sleep deprived
and fearful of surrogate decision-making due to the difficulty in the “uncertainty of not knowing”
(Almerud, Alapack, Fridlund, & Ekebergh, 2007). Evidence in the literature suggest higher stress
levels experienced in the ICU increase risk for PICS-F in family members (Anderson, Arnold,
Angus, & Bryce, 2009; Azoulay et al., 2005; Gries et al., 2010; Heyland et al., 2003; KentishBarnes, Lemiale, Chaize, Pochard, & Azoulay, 2009; Kross et al., 2011; Lefkowitz, Baxt, &
Evans, 2010; Miles, Holditch-Davis, Schwartz, & Scher, 2007; Siegel, Hayes, Vanderwerker,
Loseth, & Prigerson, 2008). To date, the focus of PICS-F research has been on description,
detection, and estimation of prevalence. There is limited evidence regarding management of
distress during the ICU stay for family members who are at the highest-risk for developing
PICS-F (i.e., spouses and surrogate health decision-makers). Emerging evidence about the
increase and persistence of psychological symptoms among family members of ICU survivors
4

warrants the need for interventions to prevent PICS-F. Thus, effective, easy to implement,
innovative interventions specifically targeting the management of distress for family members
during the ICU stay are needed.

Sensation Awareness Focused Training (SĀF-T) Intervention
The approach for the study focuses on prevention of PICS-F using an innovative rapid
stress-reduction intervention called Sensation Awareness Focused Training (SĀF-T). SĀF-T is
adapted from Accelerated Resolution Therapy (ART) for psychological trauma and depression
prevention. Laney Rosenzweig at the Rosenzweig Center for Rapid Recovery developed ART
and SĀF-T. SĀF-T utilizes eye movements to rapidly eliminate negative biological sensations of
stress. SĀF-T is designed to elicit a calming response; interrupt negative thoughts, negative
feelings, and negative behaviors; and ultimately serve as a self-management stress reduction
method for individuals. This study is the first to examine the effects of SĀF-T in family
members of ICU patients.

Purpose of the Study
The purpose of this study is to assess the safety, acceptability, and feasibility of SĀF-T in
a small sample of subjects in preparation for a larger study of the intervention’s effectiveness.
The pilot study is a small-scale, stand-alone version of a larger future randomized controlled trial
(RCT) of the intervention. Pilot data will not be pooled with the future study to ensure key
features that were not possible in the pilot study are preserved (e.g., blinding in RCTs). The pilot
study carefully examines safety, intervention acceptability, protocol feasibility, and subject
adherence. The study provides important data to determine sample size required for the larger
RCT. This study is not powered to detect meaningful differences in clinically important
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endpoints, and hypothesis testing will be reserved for the larger study. Feasibility aims,
objectives and success criteria are utilized to determine overall evidence of feasibility for the
future RCT. The purpose of the future RCT will be to investigate the impact of SĀF-T to reduce
stress in spouses of critically ill, mechanically ventilated patients during the ICU hospitalization,
which may reduce their likelihood of PICS-F. The primary aim will be to test the effect of SĀFT on PICS-F among spouses of critically ill, mechanically ventilated patients. A prospective,
RCT will be used to assess the effectiveness of the intervention in the larger future study.

Primary Aim
Assess feasibility and estimate effect size of the 3-day SĀF-T intervention on PICS-F
(symptoms of stress, anxiety, depression, and PTSD) for spouses of mechanically ventilated
patients admitted to the ICU who are acting as the surrogate decision-maker for the patient.

Objective 1
Determine enrollment rate of subjects along with identification of any barriers to consent
for planning timeline of the future RCT.
Success criteria 1. a) At least 4 subjects per week can be recruited; b) at least 50% of all
eligible subjects can be enrolled; and c) at least 60% of all recruited subjects completed both
follow-up measures.

Objective 2
Determine acceptability of providing SĀF-T to subjects during the ICU stay.
Success criteria 2. a) At least 90% of recruited subjects randomized to intervention
group received 2 of the 3 scheduled doses of SĀF-T in the ICU; and b) >90% of subjects
received SĀF-T without adverse events (e.g., increased stress on post-SĀF-T assessment).
6

Objective 3
Evaluate selection of most appropriate primary outcome measures.
Success criteria 3. Measures with highest reliability (Cronbach’s alpha), more clinical
relevance, and least influenced by factors other than the intervention are the primary outcome
measures to move forward to the future RCT.

Objective 4
Estimate effect size of SĀF-T on primary outcome measures to calculate sample size for
the larger future study.
Success criteria 4. a) Large estimated effect size (>0.5) with 95% confidence intervals
for SĀF-T on outcome measures study day 1 (pre-SĀF-T in intervention group) and study day 3
(post-SĀF-T for intervention group) and sustained over time (study day 1 to study day 30, and
study day 1 to study day 90) are the primary outcome variable targets for the future study, b)
small and medium estimated effect size (<0.5) with 95% confidence intervals for SĀF-T on
outcome measures are possible secondary outcomes for a future RCT of SAT-T effectiveness.

Secondary Aim
Explore sleep in spouses during the ICU stay.

Objective 5
Test wrist actigraphy data collection on subjects during the ICU stay.
Success criteria 5. a) At least 90% of recruited subjects wore ActiWatch during the ICU
stay; and b) >90% of recruited subjects who wore the ActiWatch did not experience adverse
events (e.g., skin irritation).
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Significance and Innovation
The study is significant because SĀF-T may provide benefit through reducing symptoms
of PICS-F in spouses of critically ill, mechanically ventilated patients during and after the ICU
stay. High stress levels in spouses during the ICU stay can have a significant impact on their
psychological wellbeing. Findings gained from this study provide preliminary data to determine
feasibility of SĀF-T in the ICU setting and estimate effect size for a larger future study.
Additionally, if proven to be effective, SĀF-T represents a widely available, low cost, simple to
implement, non-pharmacologic intervention that can be used by nurses and other clinicians to aid
in reducing symptoms of PICS-F. The study is consistent with the National Institute of Nursing
Research strategic plan to advance management of symptoms during chronic and critical illness
and promote family-centered care. The study is innovative as the first to assess feasibility of
SĀF-T among spouses of critically ill, mechanically ventilated patients.
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CHAPTER TWO:
LITERATURE REVIEW

The chapter includes a review of the literature relevant to ICU experiences of family
members and development of PICS-F, as well as intervention outcomes that led to the scientific
premise for the study. ICU experiences of family members found in the literature that are
strongly associated with PICS-F include surrogate health decision-making and sleep
disturbances. Evidence found in the literature on prevalence of PICS-F conditions, along with the
psychological, physiological, and social consequences are discussed. Also included in this
chapter are the interventions to date for PICS-F and the theoretical basis for the SĀF-T
intervention.

Conceptual Framework

Figure 2. Conceptual SĀF-T (Sensation Awareness Focused Training) to prevent PICS-F (Post
Intensive Care-Family) model.
The conceptual frame work presented in Figure 2 represents a family-centered
intervention, which may reduce risk of PICS-F in family members of patients admitted to ICU.
The conceptual framework guided the following review of the literature.
9

Surrogate Health Decision-Making
Amid the perceived chaos of an ICU admission and stay, family members are often asked
to make decisions that center around the life and death of their loved ones. Pochard and
colleagues (2005) found that 73% of hospitalized patients required surrogate health decisionmaking most commonly from a family member. Surrogate health decision-making is even higher
in critically ill, mechanically ventilated patients, who are typically sedated. Family members are
fearful of surrogate health decision-making due to the difficulty in the “uncertainty of not
knowing” (Almerud, Alapack, Fridlund, & Ekebergh, 2007). Surrogate health decision-making
can have adverse psychological outcomes for family members that last long after the ICU stay
(Azoulay et al., 2005; Hickman, Daly, Douglas, & Clochesy, 2010; Petrinec, Mazanec, Burant,
Hoffer, & Daly, 2015; Sullivan et al., 2012).

Sleep Disturbances
Inside the crowded, beeping, blinking, alarming ICU room, normal sleep is disrupted and
concerns about the patient may make sleep difficult when the family member is not at the
hospital. Family members report sleep disturbances as one of the top stressors during the ICU
stay (Netzer & Sullivan, 2014; Novaes et al., 1999; Verceles et al., 2014). Sleep adequacy is
defined as a combination of three factors: latency (the time it takes to fall asleep), efficiency
([time spent sleeping ÷ total time in bed] × 100), and duration of sleep (Morin & Espi, 2003).
According to the American Academy of Sleep Medicine (2000) for adequate sleep, persons
should fall asleep within 15 minutes, stay asleep for at least 85% of the time they are in bed, and
have a total sleep time of no less than 7 hours. Reasons reported by family members for sleep
disturbances include environmental noise, anxiety, tension, and fear (Day, Haj-Bakri,
Lubchansky, & Mehta, 2013). Sleep disturbances may play a role in the development of PICS-F
10

(Davidson, Jones, & Bienvenu, 2012; Verceles et al., 2014). Although anxiety, tension, and fear
are to be expected when a family member is critically ill, acknowledging these feelings and
practicing stress-reducing techniques can reduce the impact these feelings have on sleep
(Chesson et al., 1999). Therefore, management of stress in family members throughout the
daytime may improve nighttime sleep and reduce risk of PICS-F.
Post Intensive Care Syndrome –Family (PICS-F)
There is strong evidence that family distress in response to critical illness is prevalent
during the ICU stay and does not disappear after ICU discharge or death of the patient. The
Society of Critical Care Medicine (2013) identified a cluster of complications that occur in
family members from exposure to critical care as post intensive care syndrome-family (PICS-F).
PICS-F conditions include acute stress disorder (ASD), anxiety, depression, posttraumatic stress
disorder (PTSD), and complicated grief. In review of the literature, a sample of 34 studies related
to PICS-F conditions were identified from around the world. These studies include 5,571
subjects from 23 (68%) prevalence studies and 11 (32%) intervention studies. A literature search
flow diagram (See Figure 3) and summarization table of these studies (See Table 1) can be found
at the end of this chapter.

Acute Stress Disorder (ASD)
ASD is the development of severe anxiety and dissociative symptoms within 3 days to a
maximum of 4 weeks of event exposure (American Psychiatric Association [APA], 2013). Data
suggest approximately 30% of parents of critically ill children experience symptoms of ASD
(Lefkowitz, Baxt, & Evans, 2010; Shaw, Bernard, Deblois, Ikuta, Ginzburg, & Koopman, 2009).
Two prevalence studies on ASD were limited to parents of critically ill children and did not use
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the same measurement instruments. The results of these studies conflicted on the prevalence of
ASD by sex of the parent. Shaw and colleagues (2009) found in their baseline measures (n=40)
during the first few weeks of ICU admission, 44% of mothers (n=11) were classified as meeting
the symptom criterion for ASD, while none of the fathers (n=0) met this criterion, suggesting
ASD was associated with the female sex. However, at follow-up measures (n=18, 45% retention
rate) 4-months post-birth of their premature infant, 33% of fathers (n=2) and 9% of mothers
(n=1) met criterion for PTSD (Shaw et al., 2009). Lefkowitz and colleagues (2010) discovered
from their study (n=127) that 35% of mothers (n=30) and 24% of fathers (n=10) met ASD
diagnostic criterion during the ICU, and 15% of mothers (n=9) and 8% of fathers (n=2) met
PTSD diagnostic criterion 1-month later (Lefkowitz et al., 2010). The conflicting prevalence of
ASD in the male sex is most likely contributed to the differences in sample size and instruments
used to assess ASD. Currently, there is a gap in the literature on the prevalence of ASD in family
members of adult critically ill patients, as well as intervention studies for ASD.

Ongoing Anxiety
Anxiety disorder is disproportionate anxiety and worry that remains present for at least 6months, with a minimum of three additional symptoms (i.e., restless, on edge, fatigue, trouble
concentrating, irritable, tight muscles, and sleep difficulty) (American Psychiatric Association
[APA], 2013). Data suggest up to 44% of family members of critically ill patients experience
symptoms of anxiety (Fotiou et al., 2016; Melnyk, Crean, Feinstein, & Fairbanks, 2008;
Zelkowitz et al., 2011). Three randomized intervention studies on anxiety were limited to parents
of critically ill children (Fotiou et al., 2016; Melnyk et al., 2008; Zelkowitz et al., 2011). The
same instrument was used to measure anxiety (State Trait Anxiety Index) at 2 to 3-months postICU experience. Fotiou et al. (2016) used three relaxation techniques (deep breathing, guided
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imagery, and progressive muscle relaxation) as an intervention and the control group received
general information about infants. Both intervention and control groups (n=59) experienced a
decrease in anxiety at 3-months post-ICU experience, with no significant difference between
groups (Fotiou et al., 2016). Data suggest the effect of the intervention (relaxation techniques)
was better with higher baseline anxiety scores (Fotiou et al., 2016). Zelkowitz et al. (2011)
compared two educational programs, CUES versus CARE, as interventions to reduce anxiety in
mothers (n=121). More than half of the mothers experienced anxiety scores in the clinical range
at baseline. Both groups reported fewer symptoms of anxiety post-intervention, with no
significant difference between the two groups (Zelkowitz et al., 2011). Melnyk and colleagues
(2008) conducted a secondary analysis on the Creating Opportunities for Parent Empowerment
(COPE) intervention for mothers (n=246). Mothers experienced a decrease in anxiety at 2months post ICU experience. Maternal anxiety was only related to beliefs during the ICU and not
related post hospital (Melnyk et al., 2008). Data from all three studies suggest anxiety in parents
of neonate ICU survivors decreases over time, without a significant difference among education
and relaxation interventions (Fotiou et al., 2016; Melnyk et al., 2008; Zelkowitz et al., 2011).

Depression
Episodes of depression can be mild, moderate, or severe. Depressive episodes may
include sadness, loss of joy, low energy, a decrease in self-esteem, guilt, pessimistic thoughts,
disrupted sleep, lack of appetite, and suicidal thoughts (APA, 2013). Data suggest up to 36% of
family members of critically ill patients experience symptoms of depression (Choi et al., 2014;
Davydow, Hough, Langa, & Iwashyna, 2012; Lemaile et al., 2010; Miles, Holditch-Davis,
Schwartz, & Scher, 2007; Mulder, Carter, Frampton, & Darlow, 2014; Pinelli et al., 2008). There
were 6 prevalence studies on depression in family members of ICU patients. Of these, 3 studies
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recruited family of adult ICU patients, and 3 studies recruited parents of children in the ICUs.
Choi and colleagues (2014) completed a secondary analysis in family members (n=47) of adult
ICU survivors. Measures of depression associated with fatigue were collected at three different
time points post-ICU experience (< 2-weeks, 2-months, & 4-months). Mean depression scores
remained substantial during each time point, and more so in the presence of clinically significant
fatigue (Choi et al., 2014). Davydow and colleagues (2012) prospectively examined spouses
(n=865) of sepsis survivors. Measures of depression were assessed at an average of 1.1-years
post-ICU experience. Approximately 34% of wives experienced substantial depressive
symptoms, while 25% of husbands experienced substantial depressive symptoms (Davydow et
al., 2012). Lemaile and colleagues (2010) followed-up with family (n=284) of adult ICU
patients. Measures were obtained on their mental health and quality of life at 3-months following
their ICU experience. Approximately 36% of family members were taking medications for
anxiety and depression. Factors that influenced mental health scores include admission for shock,
end-of-life decisions, age, female sex, adult child, lower income, chronic disease, newly
prescribed psychotropic medications, and perceived conflicts with ICU staff (Lemaile et al.,
2010). Overall, a range of 25% to 36% of family members of adult patients experienced
symptoms of depression from 2-months to over 1-year post-ICU experience (Choi et al., 2014;
Davydow et al., 2012; Lemaile et al., 2010). Although the event of admitting a child to the ICU
may be particularly stressful, Mulder and colleagues (2014) did not find any difference in
psychological distress or depression after 2-years in parents whose infants were admitted to an
ICU compared with control parents (Mulder et al., 2014). Pinelli and colleagues (2008) observed
depression scores in mothers of sick newborns in the ICU. Depression scores in mothers ranged
from 12% to 16% and in fathers from 7% to 12% at 3-months and 12-months post-ICU
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experience respectively (Pinelli et al., 2008). Miles and colleagues (2007) observed similar
results. Depression scores tapered down to a range of 12% to 21% at 6-months and 27-months
post-ICU experience in mothers of sick newborns (Miles et al., 2007). Over the long term, data
suggest depression is less prevalent in parents of sick newborns, ranging from 7% to 21% (Miles
et al., 2007; Mulder et al., 2014; Pinelli et al., 2008) when compared to family members of
critically ill adults, ranging from 25% to 36% prevalence (Choi et al., 2014, Davydow et al.,
2012; Lemaile et al., 2010).

Posttraumatic Stress Disorder (PTSD)
PTSD can be subclinical, in which the criteria are almost, but not fully met, or meets all
eight criteria for a clinical diagnosis. The eight criteria for PTSD include: experiencing a
traumatic event, re-experiencing the traumatic event, avoidance, negative alterations in
cognitions, alterations in arousal and reactivity, duration of symptoms is >1-month, clinically
significant distress, or impairment in functioning, and unrelated to other medical conditions or
substances (APA, 2013). Of note, ASD, anxiety, and depression may be secondary to PTSD
(Azoulay et al., 2005). Data suggest up to 75% of family members of critically ill patients
experience symptoms of PTSD (Azoulay et al., 2005; van den Born-van Zanten, Dongelmans,
Dettling-Ihnenfeldt, Vink, & van der Schaaf, 2016; Bronner, Knoester, Bos, Last, &
Grootenhuis, 2008; Colville, Cream, & Kerry, 2010; Feeley et al., 2011; Fumis, Ranzani,
Martins, & Schettino, 2015; Garrouste-Orgeas et al., 2012; Jones, Bäckman, & Griffiths, 2012;
Kross et al., 2011; McAdam, Fontaine, White, Dracup, & Puntillo, 2012; de Miranda et al., 2011;
Petrinec, Mazanec, Burant, Hoffer, & Daly, 2015; Rosendahl, Brunkhorst, Jaenichen, & Strauss,
2013; Wolters et al., 2014). There were 14 studies with PTSD as the primary focus. Of these,
there were 11 prevalence studies, and 3 intervention studies. The 11 prevalence studies included
15

family members of both critically ill children and adults. PTSD was assessed as early as 1-month
up to 55-months post-ICU experience. The range of PTSD prevalence was 21% to 75% of family
members (Azoulay et al., 2005; van den Born-van Zanten et al., 2016; Bronner et al., 2008;
Feeley et al., 2011; Fumis et al., 2015; Kross et al., 2011; McAdam et al., 2012; de Miranda et
al., 2011; Petrinec et al., 2015; Rosendahl et al., 2013; Wolters et al., 2014). Risk factors
included spouses (Fumis et al., 2015; Rosendahl et al., 2013), surrogate decision-makers
(Azoulay et al., 2005; McAdam et al., 2012; de Miranda et al., 2011; Petrinec et al., 2015),
incomplete information provided in the ICU (Azoulay et al., 2005), present at the time of death
(Kross et al., 2011), and peritraumatic dissociation (de Miranda et al., 2011). Three intervention
studies use augmented communication strategies as interventions for PTSD. Two studies
augmented communication with ICU diaries (Garrouste-Orgeas et al., 2012; Jones et al., 2012).
A third study augmented communication with follow-up outpatient clinic visits (Colville et al.,
2010). Data suggest ICU diaries may significantly affect symptoms of PTSD at 3-months and
12-months post-ICU experience (Garrouste-Orgeas et al., 2012; Jones et al., 2012). No
significant difference was found in offering parents of PICU survivors a follow-up clinic
appointment (Colville et al., 2010).

Complicated Grief
Complicated grief is a proposed disorder in psychiatry for those who are significantly
impaired by grief symptoms for at least 1-month beyond 6-months of bereavement (APA, 2013).
Data suggest the prevalence of complicated grief may be as high as 52% in family members of
patients who die in the ICU (Anderson et al., 2008; Gries et al., 2010; Kentish-Barnes et al.,
2017; Meert et al., 2011; Siegel et al., 2008). There were nine studies on complicated grief. Of
these, there were five prevalence studies, and four intervention studies. The five prevalence
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studies include family members of both children and adults who died in the ICU (Anderson et
al., 2008; Gries et al., 2010; Kentish-Barnes et al., 2017; Meert et al., 2011; Siegel et al., 2008).
Risk factors associated with complicated grief include female sex (Gries et al., 2010; KentishBarnes et al., 2017), spousal role (Siegel et al., 2008), being the biological parent with no other
children (Meert et al., 2011), patient refusal of treatment (Kentish-Barnes et al., 2017), patient
died while intubated (Kentish-Barnes et al., 2017), discordance with surrogate health decisionmaking (Gries et al., 2010), patient illness < 5-years (Gries et al., 2010; Siegel et al., 2008),
lower education level (Anderson et al., 2008), experiencing additional stressors after the loss
such as living alone (Kentish-Barnes et al., 2017; Siegel et al., 2008), present at time of death
(Kentish-Barnes et al., 2017), did not get a chance to say goodbye (Kentish-Barnes et al., 2017),
poor communication with ICU staff or amongst relatives (Kentish-Barnes et al., 2017), history of
psychiatric treatment (Gries et al., 2010), and presence of PTSD (Anderson et al., 2008). The
four randomized intervention studies utilized education and communication strategies as
interventions for complicated grief. The education intervention was a randomized controlled trial
that invited family members (n=58) to remain present at the bedside during brain death
evaluation (Tawil et al., 2014). There was no difference in the psychological well-being between
the intervention and control groups at 1-month and 3-months. Data suggests family presence
during brain death evaluation is feasible and safe (Tawil et al., 2014). The communication
intervention consisted of detailed guidelines to follow during the end-of-life conference with
family members, at which time they received a brochure on bereavement (Lautrette et al., 2007).
There was a significant difference (p < .05) of fewer symptoms of complicated grief in the
intervention group compared with the control group. Another communication intervention
consisted of a nurse or social worker trained in the role of communication facilitator (Curtis et
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al., 2013). There was no significant difference in the psychological well-being of family
members between the intervention and control groups. Lastly, a communication intervention in
the form of a condolence letter by the ICU team was sent to family members at 15-days post
death. The condolence letter failed to alleviate grief symptoms and may have worsened
depression and PTSD-related symptoms (Kentish-Barnes et al., 2017). The evidence from these
intervention studies suggests additional procedural education and enhanced communication in
the ICU may lessen the burden of bereavement for family members.

Physiological and Social Consequences of PICS-F
PICS after ICU discharge does not only affect the patient, but also reduces the physical,
mental, social, and financial position of their family members. Physiological consequences of
PICS-F include lack of physical energy, lack of sleep, lack of appetite, and lack of self-care
(Wolters et al., 2014). Social consequences of PICS-F include interruptions in routine, role, and
responsibilities of the family; delayed life plans; family conflicts; and stigmatization (Wolters et
al., 2014). Studies report that almost 50% of family members, who were employed at study
enrollment, reduced their work hours, quit their job, or were fired in order to provide informal
care (Douglas, Daly, O'Toole, & Hickman, 2010; Swoboda et al., 2002). Swoboda and
colleagues (2002) found that 38% of family members reported it was somewhat difficult to pay
for basic needs such as food, housing, medical care, and heating. PICS-F also interferes with
family members’ ability to perform care, and ICU survivors require care long after hospital
discharge (Johansson, Fridlund, & Hildingh, 2004; Scott & Arslanian-Engoren, 2002).
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Interventions for PICS-F
To date, the focus of PICS-F research has been on description, detection, and prevalence
using self-report measures. Early psychological screening among family members of the
critically ill can identify individuals who may benefit from interventions that prevent further
psychological impairment. However, there are limited numbers of interventional studies for
PICS-F conditions. The majority of interventions were designed around communication or
education in the ICU. Communication interventions consist of providing pro-active end-of-life
family conferences with bereavement brochures (Lautrette et al., 2007), utilizing
interprofessional communication facilitators (Curtis et al., 2013), palliative care-led meetings for
families of patients with chronic critical illness (Carson et al., 2016), implementing ICU diaries
(Garrouste-Orgeas et al., 2012; Jones, Bäckman, & Griffiths, 2012), offering follow-up clinic
visits (Colville, Cream, & Kerry, 2010), and sending condolence letters (Kentish-Barnes et al.,
2017). Among these communication studies, multidisciplinary teams were required to facilitate
the meetings with family members. Even though some results are promising with reduced ICU
length of stay and increased palliative care consultations, the adherence to early and routine
family conferences was usually low and conferences happened late in the disease course. In
some of the studies, signals from the qualitative results did not always match the quantitative
results, indicating the intervention did not work with signals of harm noted (Carson et al., 2016;
Curtis et al., 2013; Kentish-Barnes et al., 2017). Educational interventions include Creating
Opportunities for Parent Empowerment (COPE) (Melnyk et al., 2008), infant CUES and CARE
programs (Zelkowitz et al., 2011), stress management education with relaxation techniques
(Fotiou et al., 2016), and family presence during brain death evaluation with education at the
bedside (Tawil et al., 2014). Most of the educational studies are targeted for parents of the
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pediatric patient population (Melnyk et al., 2008; Zelkowitz et al., 2011; Fotiou et al., 2016).
Few studies that targeted family members of adult ICU patients provided the rigor of randomized
controlled trials (Lautrette et al. 2007; Curtis et al. 2013; Jones, Bäckman, & Griffiths, 2012).
Thus, low-cost, easy to implement, family-centered interventions need to be developed and
rigorously tested with family-centered outcomes to reduce risk of PICS-F.

Sensation Awareness Focused Training Intervention (SĀF-T)
Laney Rosenzweig at the Rosenzweig Center for Rapid Recovery developed SĀF-T. This
study is the first randomized controlled trial to use SĀF-T as an intervention. SĀF-T is adapted
from Accelerated Resolution Therapy (ART), which combines eye movements used in eye
movement desensitization and reprocessing (EMDR) with Gestalt techniques, metaphors, and
solution-focused emphasis. The Substance Abuse and Mental Health Services Administration
(SAMHSA) designated ART to be an evidence-based treatment for trauma-related disorders,
depression, and personal resilience. Studies have reported beneficial clinical effects of ART for
treatment of symptoms of PTSD in both civilians and veterans (Kip et al., 2012; Kip et al.,
2013). SĀF-T uses an adapted approach from ART to rapidly eliminate negative biological
sensations of stress. The SĀF-T intervention takes approximately 15-20 minutes per session. The
SĀF-T intervention includes scripted coaching from SĀF-T trained research staff on awareness
of biological sensations. Research staff sit across from the subject and ask them to use their eyes
to follow hand movements that induce lateral left-right (smooth pursuit) eye movements
followed with slow deep breaths. These actions in the SĀF-T intervention shift autonomic
balance toward parasympathetic dominance.
The theoretical basis for SĀF-T is psychophysiological. The scripted coaching in SĀF-T
engages working memory. Taxing of working memory renders traumatic images less vivid and
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emotional (Lee & Cuijpers, 2013; van den Hout, Muris, Salemink, & Kindt, 2001). Therefore,
the secondary task of eye movements in SĀF-T reduce vividness and emotionality of mental
images through interplay of dual taxation of working memory (Gunter & Bodner, 2008). Thus,
the distressing memory that elicits stressful sensations cannot be retrieved completely and in turn
lessens the impact of stress induced sensations.
Additionally, episodic memory recall of personal (autobiographical) facts, is facilitated
by increased interaction between two cerebral hemispheres. The sequences of left–right bilateral
eye movements result in simultaneous activation of both cerebral hemispheres (Christman,
Garvey, Proper, & Phaneuf, 2003). Because the majority of eye movements during REM sleep
are horizontal (Hansotia, Broste, So, Ruggles, Wall, & Friske, 1990), this evidence suggests that
bilateral eye movements are associated with increased interhemispheric interaction and
coordination. Facilitating episodic memory increases taxation on working memory, which
dampens the vividness and emotionality, thereby diminishes stress induced sensations.
Evidence in the literature also suggests repetitive eye movements may activate the
parasympathetic nervous system and relaxation response (Barrowcliff, Gray, MacCulloch,
Freeman, & MacCulloch, 2003; Elofsson, von Scheele, Theorell, & Sondergaard, 2008; Obrist,
1981; Stickgold, 2002). Lastly, the mindful deep breathing in SĀF-T relieves stress and anxiety
due to its physiological effect on the parasympathetic nervous system (Jerath, Edry, Barnes, &
Jerath, 2006). Collectively, dual taxation of working memory, increased interhemispheric
interaction, smooth pursuit eye movements, and slow deep breathing shift autonomic balance
towards parasympathetic dominance. (Barrowcliff, Gray, MacCulloch, Freeman, & MacCulloch,
2003; Elofsson, von Scheele, Theorell, & Sondergaard, 2008; Jerath, Edry, Barnes, & Jerath,
2006; Obrist, 1981; Stickgold, 2002).
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The sympathetic nervous system controls the body's fight or flight response to perceived
threats (Science Daily, 2018). Anxiety, tension, and fear are to be expected when a loved one is
critically ill; thus, it is likely the autonomic balance of family members shift towards sympathetic
dominance during the ICU stay. SĀF-T shifts the autonomic balance back towards
parasympathetic dominance. The parasympathetic nervous system controls homeostasis and is
responsible for the body's rest and digest function by reducing activity of the brain, the muscles,
and the adrenal and thyroid glands (Science Daily, 2018). SĀF-T may enhance rest and sleep
through shifting the autonomic balance towards parasympathetic dominance. During rest and
restorative sleep, the parasympathetic system renews and heals any damage to the body caused
by an over-active sympathetic nervous system (Science Daily, 2018). Autonomic system
measures along with sleep/rest actigraphy in family members during the future RCT would be
advantageous in assessing the affect SĀF-T may have on the balance between the sympathetic
and parasympathetic systems and sleep, which may be important in decreasing risk of PICS-F.

Summary
As demonstrated in the foregoing literature review, exploration of both experimental and
non-experimental PICS-F research brings to light the need for new ideas in designing
interventions, beyond communication and education protocols, to support family members
during and after the critical illness of their loved ones (Turner-Cobb, Smith, Ramchandani,
Begen, & Padkin, 2016). The scientific premise for the study is based on the substantial
challenge to manage symptoms of stressful events experienced by family members during the
ICU stay, and an intriguing, innovative intervention with psychophysiological rationale that
supports the SĀF-T protocol as a promising approach to reduce risk of PICS-F. The SĀF-T
intervention is an easy to implement, low-cost, non-pharmacological intervention that could be
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used to reduce psychological distress in family members of patients admitted to ICU. There is
enormous opportunity to rethink and redesign how critical care is provided to include both
patients and their family as a unit in need of care for optimal outcomes. This study promotes
family-centered care to advance the management of symptoms of stressful events during the ICU
experience and improve outcomes post ICU and hospital discharge for both patient and family.
Below is a flow diagram of the literature search specific to PICS-F research (See Figure 3).

Included

Eligibility

Screening

Identification

Table 1 presents a summarization of the PICS-F studies by prevalence and interventions.
Additional records identified
through other sources:
(n = 7)

Records identified through database
searching:
(n = 1,121)

Records after limits applied:
(n = 304)

Records screened:
(n = 304)

Records excluded:
(n = 241)

Full-text articles assessed
for eligibility:
(n = 63)

Reasons full-text articles
excluded:
2 No evaluation on family
27 No post ICU measures
(n = 29)

Studies included in
literature review:
(n =34)

Figure 3. Flow diagram of literature search.
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Table 1. Summarization of PICS-F Studies by Prevalence and Interventions

Author, year, and
location
Anderson et al.,
2008
United States

Azoulay et al.,
2005
France

Bronner et al.,
2008
Netherlands

Choi et al.,
2014
United States

Davydow et al.,
2012
United States

Feeley et al.,
2011
Canada

Fumis et al.,
2015
Brazil

Gries et al.,
2010
United States

Prevalence Studies
Design, sample size,
PICS-F conditions assessed
Outcomes of PICS-F conditions
and instruments
Prospective longitudinal cohort;
Comparing measurements at baseline, 1 month, & 6
N = 50 relatives
months post discharge, symptoms of anxiety and
PICS-F conditions: Symptoms of
depression diminished over time, but both bereaved
anxiety, depression, PTSD &
and non-bereaved participants had high rates of
complicated grief
posttraumatic stress & complicated grief. Prevalence
Instruments: Hospital Anxiety and
of complicated grief was 46% & PTSD was 35% at 6
Depression (HAD), Impact of Events
months post-ICU experience.
Scale (IES), Inventory of Complicated
Grief (ICG)
Prospective longitudinal cohort;
At 3 months post discharge, severe post-traumatic
N = 284 relatives
stress reaction was associated with increased rates of
PICS-F conditions: Symptoms of
anxiety and depression and decreased quality of life
anxiety, depression & PTSD
in family members.
Instruments: HAD, IES & Short Form
(SF)-36
Prospective follow-up;
At 3 months & 9 months post discharge, more than
N = 144 parents
three-quarters of the parents experienced persistent
PICS-F conditions: Symptoms &
symptoms of PTSD. In 15% of mothers and 9.3% of
diagnosis of PTSD
fathers, the full psychiatric diagnosis of PTSD was
Instruments: Social Relationship
determined by a psychologist. In six families, both
Satisfaction (SRS)-PTSD
parents had PTSD.
Secondary analysis of a longitudinal
Comparing measures at 2 weeks, 2 months & 4
study;
months, caregiver depressive symptoms and health
N = 47 family caregivers
risk behaviors were highly prevalent and correlated
PICS-F conditions: Symptoms of
with each other while their loved ones were in the
depression
ICU. During the initial two months following ICU
Instruments: Center for Epidemiologic
discharge, close to half of caregivers continued to
Studies-Depression (CES-D)
report high levels of depressive symptoms, greater
burden, and more health risk behaviors.
Prospective, longitudinal cohort;
At 1-year post discharge, each additional impairment
N = 865 spouses
of ADLs that a severe sepsis survivor had was
PICS-F conditions: Symptoms of
associated with a 35% increase in the odds of
depression
substantial depressive symptoms in their wife.
Instruments: CES-D
Descriptive correlational;
At 6 months post discharge, 23% of mothers scored
N = 21 mothers
in the clinical range on a measure of PTSD.
PICS-F conditions: Symptoms of
PTSD
Instruments: (PPQ)
Prospective study;
Comparing measures during ICU, and 1 month & 3
N = 184 spouses
months post discharge, anxiety, depression, and
PICS-F conditions: Symptoms of
posttraumatic stress symptoms are higher and persist
anxiety, depression & PTSD
longer in family members than in patients.
Instruments: HAD & IES
Follow-up survey study;
At 6 months post death in the ICU, PTSD and
N = 226 family members; PICS-F
depressive symptoms in family members were 14.0%
conditions: Depression & PTSD
and 18.4%, respectively.
Instruments: PCL & PHQ-8
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Table 1 (Continued)
Kross et al.,
2011
United States

Cohort follow-up survey associated
with a cluster randomized trial;
N = 226 family members
PICS-F conditions: Symptoms of
depression & PTSD
Instruments: PCL, PHQ-8

Lefkowitz et al.,
2010
United States

Prospective longitudinal survey;
N = 127 parents
PICS-F conditions:
Symptoms of ASD, depression &
PTSD
Instruments: Acute Stress Disorder
Scale (ASDS), PCL, & Postpartum
Depression Screening Scale (PDSS)
Multicenter observational study;
N = 284 relatives
PICS-F conditions: Symptoms of
anxiety & depression
Instruments: SF-36 - Mental
Component Summary

Lemiale et al.,
2010
France

At 6 months post death in the ICU, Family members
of older patients had lower scores for PTSD. Family
members that were present at the time of death and
family members of patients with early family
conferences reported higher symptoms of PTSD.
When withdrawal of a ventilator was ordered, family
members reported lower symptoms of depression
35% of mothers and 24% of fathers met ASD
diagnostic criteria during the ICU, and 15% of
mothers and 8% of fathers met PTSD diagnostic
criteria 1 month later. PTSD symptom severity was
correlated with concurrent stressors and family
history of anxiety and depression.

McAdam et al.,
2012
United States

Longitudinal descriptive study;
N = 41 relatives
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: HAD & IES

Meert et al.,
2011
United States

Longitudinal follow-up survey; N =
138 parents
PICS-F conditions: Symptoms of
complicated grief
Instruments: ICG
Longitudinal descriptive study;
N = 102 mothers
PICS-F conditions: Symptoms of
depression
Instruments: CES-D
Prospective multicenter study; N = 102
relatives
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: HAD & IES
2-year follow-up; N=420 parents
PICS-F conditions: Depression
Instruments: EPNDS

Miles et al.,
2007
United States

de Miranda et al.,
2011
France

Mulder et al.,
2014
New Zealand
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The SF-36 showed evidence of impaired mental
health in relatives of ICU patients 90 days after
discharge or death. 35.9% of relatives were taking
anxiolytic or antidepressant drugs, and 8.4% were
taking psychotropic agents prescribed since the
discharge or death of the patient. Among factors
independently associated with a worse mental score,
2 were patient-related (admission for shock or
implementation of end-of-life decision), 6 were
family-related (older age, female gender, child of the
patient, low income, chronic disease, and newly
prescribed psychotropic medications), and 1 was
related to the ICU experience (perceived conflicts
between ICU staff and relatives).
Even though symptoms (compared during the ICU
and at 3 months post discharge) decreased over time,
many of the family members scored at or higher than
the cut-off levels on the IES-R and the HADS
instruments, indicating that the members were still at
high risk for PTSD, anxiety, and depression.
ICG scores at 6 months and 18 months represented
an improvement. Complicated grief was present in
59% of parents at 6 months and 38% of parents at 18
months.
Mean depressive symptoms scores on the CES-D
during hospitalization were high in 63% of mothers
indicating risk of depression. Depressive scores
declined over time until 6 months and then were
fairly stable.
Symptoms of anxiety and depression prevalence in
relatives were 72.2% and 25.7% at intensive care
unit discharge and 40.4% and 14.9% on day 90,
respectively. PTSD symptoms were found in 29.8%
of relatives on day 90.
There are no significant long-term negative
psychological effects on parents whose infants were
admitted to a NICU.

Table 1 (Continued)
Pinelli et al.,
2008
Canada
Petrinec et al.,
2015
United States

Rosendahl et al.,
2013
Germany

Shaw et al.,
2009
United States

Siegel et al.,
2008
United States

Van den Born–
Van Zanten et
al., 2016
Netherlands
Wolters et al.,
2014
Netherlands

Author, year, and
location
Carson et al.,
2016
United States

Correlational longitudinal study;
N = 152 parents
PICS-F conditions: Depression
Instruments: CES-D
Single-group descriptive longitudinal
correlational study;
N = 77 family members
PICS-F conditions: PTSD
Instruments: PTSS & IES
Prospective study;
N = 55 spouses
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: HAD & PTSS
Longitudinal follow-up survey;
N = 40 & 18 parents
PICS-F conditions: ASD, anxiety,
depression & PTSD
Instruments: Parental Stressor Scale:
Neonatal Intensive Care Unit
(PSS:NICU) and Stanford Acute Stress
Reaction Questionnaire (SASRQ)
Davidson Trauma Scale, Beck
Depression Inventory-II, & Symptom
Check List-90-R
Cross-sectional survey cohort;
N = 41 next of kin
PICS-F conditions: Criteria for anxiety,
depression, & complicated grief
Instruments: ICG & clinical interview
by a psychologist
Questionnaire cohort; N=94 relatives
PICS-F conditions: PTSD
Instruments: Trauma Screening
Questionnaire (TSQ)

Although the frequency of depression decreases after
the first 3 months for most parents, 20% of parents
continue to report depression over the next 9 months.
Avoidant and Problem-Focused coping strategy use
is a significant predictor of posttraumatic stress
symptom severity 60 days after hospitalization in
family decision makers of ICU patients
Interventions to treat posttraumatic stress symptoms
after critical illness to improve mental health-related
quality of life should consider spouses at 55 months.

At 2-4 weeks following ICU admission, 28% of
parents had ASD from the stress of having an infant
hospitalized in the ICU; 44% of mothers were
classified as meeting the symptom criteria for ASD,
although none of the fathers did.
At 4 months post birth of their premature infant, 33%
of fathers, and 9% of mothers met criteria for PTSD.

Following 3-12 months post death in the ICU, 34%
next of kin met criteria for at least one psychiatric
illness: 27% had major depressive disorder, 10% had
generalized anxiety disorder, 10% had panic
disorder, & 5% had complicated grief disorder.
At 3 months post discharge, PTSD-related symptoms
were seen in 21% of the caregivers. This study shows
that relatives of ICU survivors could experience
strain 3 months after hospital discharge and are at
risk of developing PTSD-related symptoms.
Family completed the TSQ in 59 cases, of whom
15% were likely to suffer from PTSD. These
findings support the presence of PICS in family
members at 3 months.

Descriptive cohort follow-up;
N = 88 relatives
PICS-F conditions:
Symptoms of PTSD
Instruments: TSQ
Intervention Studies
Design, sample size,
PICS-F conditions assessed
Outcomes of PICS-F conditions
and instruments
Multicenter RCT with family surrogate At 3 months, there was no significant difference in
decision-makers – at least 2 palliative
anxiety and depression symptoms between groups.
care-led family meetings;
PTSD symptoms were higher in the intervention
N= 365family members
group. Use of palliative care-led informational and
PICS-F conditions:
emotional support meetings compared with usual
Symptoms of anxiety, depression &
care did not reduce anxiety or depression symptoms
PTSD
and may have increased posttraumatic stress disorder
Instruments: HADS & IES
symptoms.
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Table 1 (Continued)
Colville et al.,
2010
United Kingdom

Curtis et al.,
2013
United States

Fotiou et al.,
2016
Greece

Garrouste-Orgeas
et al.,
2012
France

Jones et al.,
2012
United Kingdom

Kentish-Barnes
et al.,
2017
France

Lautrette et al.,
2007
France

Melnyk et al.,
2008
United States

RCT with PICU Follow-up Clinic visit
2 months post discharge intervention;
N = 105 parents
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: PSS:PICU, IES, HAD
Clustered randomized trial of a
communication facilitator intervention;
N = 268 family members
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: PHQ-9, PCL &
Generalized Anxiety Disorder (GAD)-7
RCT with 3 relaxation technique (DB,
GI & PMR) interventions; N=59
parents
PICS-F conditions: anxiety
Instruments: PSS, STAI & Salivary
Cortisol
Prospective open study comparing a
diary period and the pre-diary and post
diary periods; N = 143 relatives
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: HAD & IES
Prospective experiment with ICU Diary
intervention;
N = 30 relatives
PICS-F conditions: Symptoms of
PTSD
Instruments: PTSS
Multicenter RCT;
N = 242 relatives
PICS-F conditions: Symptoms of
anxiety, depression, PTSD &
complicated grief
Instruments: HAD, IES & ICG
Prospective RCT with End-of-Life
Conference and Brochure intervention;
N = 126 family members
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: HAD & IES

RCT with COPE intervention;
N = 246 mothers
PICS-F conditions: Symptoms of
anxiety & depression
Instruments: PSS, STAI, BDI
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No significant difference with intervention. Parents
with higher baseline stress reported lower rates of
post-traumatic stress (25% vs. 57%) and depression
(19% vs. 52%) at 5 months post PICU discharge if
they had been offered an appointment than if they
had not.
There were no significant differences in
psychological symptoms at 3 months or anxiety or
PTSD at 6 months. The intervention was associated
with decreased depressive symptoms at 6 months.

Three months after discharge, both groups showed
reduced levels of anxiety, more so in the IG, but
without a statistically significant difference as a total.

The intensive care unit diary significantly affected
posttraumatic stress–related symptoms in relatives 12
months after intensive care unit discharge.
Prevention Intervention: ICU Diary

Family members of patients who received their diary
at 1 month had lower levels of symptoms related to
PTSD at the 3-month follow-up than did the control
family members.
Prevention Intervention: ICU Diary
Telephone interviews at 1-month & 6-months. In
relatives of patients who died in the ICU, a
condolence letter failed to alleviate grief symptoms
and may have worsened depression and PTSDrelated symptoms at 6-months.
On day 90, the 56 participants in the intervention
group who responded to the telephone interview had
a significantly lower median IES score than the 52
participants in the control group (27 vs. 39, P = 0.02)
and a lower prevalence of PTSD-related symptoms
(45% vs. 69%, P = 0.01). The median HADS score
was also lower in the intervention group (11, vs. 17
in the control group; P = 0.004), and symptoms of
both anxiety and depression were less prevalent
(anxiety, 45% vs. 67%; P = 0.02; depression, 29%
vs. 56%; P = 0.003).
Participation in COPE was both directly and
indirectly related to mothers’ decreased post hospital
depression and anxiety.

Table 1 (Continued)
Tawil et al.,
2014
United States

Zelkowitz et al.,
2011
Canada

RCT with being present during Brain
Death Evaluation intervention; N = 58
family members
PICS-F conditions: PTSD
Instruments: IES
RCT with educational CUES & CARE
intervention;
N = 121 mothers;
PICS-F conditions: Symptoms of
anxiety, depression & PTSD
Instruments: STAI, Perinatal PTSD,
Global Rating Scales of Mother-Infant
Interaction, Edinburgh Postnatal
Depression Scale
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Family presence during brain death evaluation
improves understanding of brain death with no
apparent adverse impact on psychological wellbeing.
The groups did not differ in levels of anxiety,
depression, and symptoms of posttraumatic stress.

CHAPTER THREE:
METHODS

This chapter presents the study methods. It is organized by design, setting, population,
sample size, measures, procedures, and data analysis plan. The chapter ends with feasibility
aims, objectives, and success criteria and study flow chart (See Figure 4).

Design
The primary aim of this study was to assess the feasibility and estimate effect size of the
3-day SĀF-T intervention on PICS-F (including stress, anxiety, depression, and PTSD) in
spouses of mechanically ventilated patients admitted to the ICU, who are acting as surrogate
health decision-makers for the ICU patient. A secondary aim of the study was to explore sleep in
spouses during the ICU stay. A prospective, randomized controlled trial design accomplished the
specific aims.

Setting
Spouses of critically ill, mechanically ventilated patients participated in the study at a
level I trauma center with 225 critical care beds.

Sample
The target sample size of 10 subjects was a reasonable representative of the target
population for the pilot study (Thabane et al., 2010). After consent, eligible subjects were
randomly assigned to one of two groups (n=5 intervention group, n=5 control group). Subjects in
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the intervention group received the SĀF-T intervention once a day over 3-days during the ICU
stay. Subjects in the control group did not receive the SĀF-T intervention. Usual care by the
healthcare team was provided to both groups (intervention and control), which included
orientation to ICU patient room and ICU waiting room, use of bathroom and shower in patient’s
room, review of ICU visiting policy with contact information, optional guest food tray, other
onsite locations to acquire food and beverages, clean towels, warm blankets, and resources for
spiritual support. Subjects in both groups met all eligibility and exclusion criteria. Eligibility
criteria included: spouses of patients intubated and admitted within 36 hours to the adult ICUs,
who were expected to remain in the ICU at least 36 hours, spouse was aged 18 years or older,
and understood English. Exclusion criteria included: anticipation by the clinical provider of
imminent patient death, spouse was under the age of 18 years old, did not understand English, or
was actively being treated for a PICS condition (stress, anxiety, depression, or PTSD).

Sample Size Justification
The sample size of 10 subjects was designed to represent the target population, assess
feasibility, and estimate effect size of SĀF-T to conduct a priori power analysis for a future RCT
investigating SĀF-T effectiveness. The sample size (n=10) was not powered to examine
effectiveness of the SĀF-T intervention.

Measures
Measures of key variables collected from subjects are outlined in Table 2.
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Table 2. Key Variables, Measures, and Data Collection Time Points
Data Collection Time Points
Study
Day 1

Measures

Study
Day 3

Study
Day 30

Study
Day 90

Concept
PICS-F
-Symptoms of Anxiety
-Symptoms of Depression
-Symptoms of PTSD

Hospital Anxiety and Depression
Scale (HADS)
Impact Event Scale (IES)

*

*

*

*

*

*

*

*

-Stress

Perceived Stress Scale (PSS)

*

*

*

*

PICS-F

NIH Toolbox Emotional Battery

*

*

*

*

Actigraphy Sleep Efficiency
(continuous over 3-days in ICU)
SĀF-T Intervention
Stress Visual Analog Scale
(daily over 3-days in ICU)
Demographic Characteristics Age, race, ethnicity, sex, level of
education, & distance of hospital
commute

*

*

*

*

Sleep/Rest

*

The instruments used to collect data were selected from the literature most commonly referenced
to measure symptoms of PICS-F conditions (stress, anxiety, depression, and PTSD). This study
is the first to measure wrist actigraphy and the NIH Toolbox Emotional Battery and administer
SĀF-T in this population.

Hospital Anxiety and Depression Scale (HADS)
HADS (Zigmond & Snaith, 1983) was used to measure anxiety and depression. HADS
has been successfully used to measure symptoms of anxiety and depression in the general
population and in family members of ICU patients (Anderson et al., 2008; Azoulay et al., 2005;
Fumis et al., 2015; Jones et al., 2004; Kentish-Barnes et al., 2017; Lemiale et al., 2010;
McAdams et al., 2012; Wolters et al., 2014). It is a 14-item self-report measure divided into 2
subscales (HADS-A & HADS-D) of 7 questions with 4 response options for each question
(weighted 0-3). Total score range for each subscale is 0-21. Score categories for each subscale:
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0-7 = normal, 8-10 = mild, 11-14 = moderate, and 15-21 = severe. Cronbach’s alpha coefficient
of internal consistency for HADS-A from .68 to .93 (mean .83), and for HADS-D from .67 to .90
(mean .82). Optimal balance between sensitivity and specificity for HADS as a screening
instrument was achieved most frequently at a cutpoint score of 8 for HADS-A and HADS-D.

Impact of Event Scale (IES)
IES is one of the earliest self-report measures of posttraumatic disturbance (Horowitz, et
al 1979). The IES is the most commonly used instrument to measure symptoms of PTSD in
PICS-F research (Davidson, Jones, & Bienvenu, 2012). The IES has been widely used for many
years and found reliable across a broad range of traumatic events (Sundin & Horowitz, 2003;
Azoulay et al., 2005; Fumis et al., 2015; Jones et al., 2004; Kentish-Barnes et al., 2017;
McAdams et al., 2012; Petrinec et al., 2015). The IES is not a tool for diagnosing PTSD, but
instead detects symptoms indicating a risk of PTSD. Each of the 15 items were scored on a 6point scale rated from 0 to 5, so that the total score can range from 0 to 75 (Horowitz, Wilner, &
Alvarez, 1979). Higher scores indicate more severe post-traumatic stress symptoms. Score
categories include 0-8 = subclinical range, 9-25 = mild range, 26-43 = moderate range, 44-75 =
severe range. A correlation of 0.42 (p< 0.01) scale scores indicates that the two subsets are
associated, but do not measure identical dimensions; test-retest reliability of 0.87 for the total
stress scores, 0.89 for the intrusion subscale, and 0.79 for the avoidance subscale.

Perceived Stress Scale (PSS)
Symptoms of stress were quantified using Cohen’s et al. (1983) PSS, which is a 10-item
measure with a total score range of 0-40. Response options include 0 = never, 1 = almost never,
2 = sometimes, 3 = fairly often, 4 = very often. It is intended to capture the degree to which
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persons perceive situations in their life as excessively stressful relative to their ability to cope.
Cronbach’s alpha is >.70 in multiple studies.

Actigraphy Sleep Efficiency
A wrist ActiWatch (ActiWatch Spectrum, Philips Respironics, Bend, OR) was placed on
the subject during study enrollment and activity and ambient light levels were measured
continuously over a 3-day period. The AcitWatch is a small, lightweight, limb-worn activity and
light-monitoring device that provides sleep/rest actigraphy based on sleep algorithms.
Polysomnography is the gold standard measurement of sleep but not feasible in the setting of the
SĀF-T study. Actigraphy is frequently used as a measure of sleep/rest in clinical research. The
accuracy of actigraphy (0.863), sensitivity (0.965), and specificity (0.329) are weakly correlated
with polysomnography (Gironda, Lloyd, Clark, & Walker, 2007; Tonetti, Pasquini, Fabbri,
Belluzzi, & Natale, 2008).

National Institutes of Health (NIH) Toolbox Emotional Battery
The NIH Toolbox Emotional Battery (version 1.11) testing was used to measure the full
spectrum of emotional health. The battery is made up of four subdomains including Negative
Affect, Psychological Well-Being, Stress and Self-Efficacy, and Social Relationships (Salsman,
Butt, Pilkonis, Cyranowski, Zill, Hendrie, Cella, et al., 2013). The subdomain stress and selfefficacy focus on individual perceptions about the nature of events and their relationship to the
perceived coping resources of the individual. In general, psychological stress occurs when and
individual perceives that the environmental or internal demands that are personally meaningful
exceed adaptive capacity (Cohen, Kessler, & Gordon,1997). The subscale perceived stress is
defined by the individual’s perceptions about the nature of events and relationship to their values
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and coping resources (Salsman et al., 2013). The subscale self-efficacy is described as a person’s
belief in their capacity to manage functioning and have control over meaningful events (Bandura,
1997). Life satisfaction subscale is the cognitive evaluation of life experiences (Salsman et al.,
2013). This measure is concerned with whether or not people like their lives. The subscale fear
affect includes feelings of fearfulness, panic, and anxious misery (Salsman et al., 2013). While
fear somatic arousal subscale reflects autonomic arousal to perceptions of threat (Salsman et al.,
2013). The subscale sadness is distinguished by low levels of positive affect and comprised of
symptoms that are primarily affective (poor mood) and cognitive (negative perceptions of self,
the world, and the future) indicators of depression (Salsman et al., 2013). Each subscale
associated with a specific subdomain has been calibrated and validated through expert panels and
factor analyses. The principal investigator attended the 3-day inaugural training by NIH in
Washington, D.C. on all domains in addition to the new 2-day training at Northwestern
University for the iPad application.
Procedures

Approval and Registration
University of South Florida Institutional Review Board granted approval for the study
(Pro00026246). The study is registered in ClinicalTrials.gov (NCT03129204).

Screening, Recruitment, and Informed Consent
The Principal Investigator (PI) made daily rounds to the adult ICUs and spoke with
charge nurses regarding availability of spouses of patients intubated and admitted within the last
36 hours and expected to stay in the ICU for at least 36 hours. Permission was obtained from the
bedside ICU nurse for the PI to approach the potential subject with an invitation to enroll in the
34

study. The potential subject was provided with an oral explanation of the nature of the study, as
well as study information in writing. The information included all elements required for
informed consent, pertinent contact information, and information about withdrawal from the
study. Written consent was obtained from subjects for study participation.

Group Assignment
A block design randomized assignment (randomizer.org) was used to determine group
assignment (intervention or control) for subjects. Following signed consent, each subject had an
equal chance of receiving the intervention with the opening of a sealed, opaque envelope to
obtain the group assignment. Usual care by the healthcare team was provided to both groups
(intervention and control), which included orientation to ICU patient room and ICU waiting
room, use of bathroom and shower in patient’s room, review of ICU visiting policy with contact
information, optional guest food tray, other onsite locations to acquire food and beverages, clean
towels, warm blankets, and resources for spiritual support.

Description of Intervention
The SĀF-T intervention takes approximately 15-20 minutes to deliver each day, over a 3day period. The SĀF-T intervention includes coaching from SĀF-T trained research staff (for
this study, the PI) on awareness of biological sensations associated with events in the ICU that
are perceived stressful. The PI sat across from the subject and asked them to use their eyes to
follow hand movements that induce lateral left-right (smooth pursuit) eye movements, followed
with deep breaths. To monitor the safety of subjects in the intervention group, immediately
before and after (pretest/posttest) each SĀF-T intervention, the subject was asked based on a
visual analog scale of 1-10 (1 being a low amount and 10 being a high amount) to rate the
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amount of stress they were currently sensing throughout their body. An increased stress level
post SĀF-T intervention would be documented an adverse event. Two consecutive adverse
events of increased stress levels post SĀF-T intervention would be considered a signal of harm
and the subject would be withdrawn from the study.

Data Collection
The collection of primary outcome measures from each subject took approximately 30
minutes during each of the four-time points for both groups: study day 1 (prior to SĀF-T for
intervention group), study day 3 (following SĀF-T for the intervention group), study day 30 (1month), and study day 90 (3-months). Post ICU follow-up data was collected by telephone
interview on or within 48 hours of study day 30 and study day 90. The ActiWatch placed on the
subject’s wrist at the time of study enrollment (study day 1) collected continuous activity and
light data over a 3-day period (study day 3).

Data Analysis Plan
IBM SPSS software, version 24 was used to assure data integrity. A review of statistical
power, test assumptions, missing data, and measurement tools provided confidence in the results
of parametric statistical procedures (Bannon, 2013). Due to the small sample size (n=10),
statistical power is insufficient (<.80) to examine all relationships between variables and detect
all significant effects. Demographic and clinical characteristics of the study sample were
described by means and standard deviations for continuous variables and percentages for
categorical variables. Since our sample size is small, it was difficult to verify the sample
characteristics were normally distributed. Therefore, distributions of these characteristics
were compared by random assignment by use of Fisher's exact test and Mann-Whitney U test.
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Given that the repeated dependent variables (n=38) stress, anxiety, depression, PTSD,
and emotional health are continuous, five principal assumptions (normal distribution,
multicollinearity, homoscedasticity, linearity, and no undue influence of outlier scores) were
examined before general linear models were used in analysis (Bannon, 2013). Scores of primary
outcome measures were approximately normally distributed. Both skewness and kurtosis were
less than twice the standard error of each measure (Bannon, 2013). No problems of
multicollinearity (correlation coefficient >.90) were detected among predictor variables.
Homoscedasticity was supported through Levene’s test of homogeneity (p>.05). Linearity
between the predictor variables and dependent variables were met. There were no outlier scores
impacting normality, thus there was no undue influence of outliers on study results. There were
no missing data through study day 1(pre-SĀF-T for intervention group) and study day 3 (postSĀF-T for intervention group) outcome measures. However, one subject was lost due to attrition
for post-ICU follow-up measures (study day 30 and study day 90). This subject’s spouse died
during the ICU stay and did not return either of the two voicemails to schedule follow-up
measures.
SAS version 9.4 was used for Repeated Measures Mixed Effects Models. Specification of
the linear mixed model was with maximum likelihood estimation and two categorical variables.
The model equation was that each outcome measure mean score was being evaluated in relation
to group assignment, assessment period (study day 1 to study day 3, study day 1 to study day 30,
and study day 1 to study day 90), and group assignment “x” assessment period for rate of change
by group over time. The specification that this was a repeated measures analysis was by the
subject ID number indicating how the data were repeated and using an unstructured covariance
matrix. The variable Group was the main effect term and compared mean scores between the
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SĀF-T and control groups across all time points, including study day 1. The variable Assessment
Period was the time variable scored as study day 1, study day 3, study day 30, and study day 90,
and evaluated whether the outcome measure scores changed over time. The variable Rate of
Change (Group “x” Assessment Period) evaluated whether the rate of change in outcome
measure scores over time differed by random assignment, which is a comparison of the slopes
for the SĀF-T and control groups. Consequences of significant differences in Rate of Change
(p<0.05) are not the scores as much as what they imply about the process underlying the scores,
which is of most relevance.

Primary Aim
Assess feasibility and estimate effect size of the 3-day SĀF-T intervention on PICS-F
(symptoms of stress, anxiety, depression, and PTSD) for spouses of mechanically ventilated
patients admitted to the ICU, for whom the spouse is the surrogate health decision-maker.

Objective 1
Determine enrollment rate of subjects along with identification of any barriers to consent
for planning timeline of future RCT.
Success criteria 1. a) At least 4 subjects per week can be recruited; b) at least 50% of all
eligible subjects can be enrolled; and c) at least 60% of all recruited subjects completed both
follow-up measures.
Analysis plan. Descriptive statistics for sample demographic and clinical characteristics
were determined as means and standard deviations for continuous variables and as frequencies
and percentages for categorical variables. Distributions of these characteristics were compared
by random assignment by use of Fisher's exact test and Mann-Whitney U-test. Weekly
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recruitment rate, enrollment rate, and measures completion rate were calculated as frequencies
and percentages.

Objective 2
Determine acceptability of providing SĀF-T to subjects during the ICU stay.
Success criteria 2. a) At least 90% of recruited subjects randomized to intervention
group received 2 of the 3 scheduled doses of SĀF-T in the ICU; and b) >90% of subjects
received SĀF-T without adverse events (e.g., increased stress on post-SĀF-T assessment).
Analysis plan. Descriptive statistics for intervention were calculated as means and
standard deviations. Wilcoxon Signed Rank Test was used to detect statistical significance of
change in pre-SĀF-T and post-SĀF-T stress visual analog scale scores. Received doses and
adverse events were calculated in frequencies and percentages.

Objective 3
Evaluate selection of most appropriate primary outcome measures.
Success criteria 3. Measures with highest reliability (Cronbach’s alpha), more clinical
relevance, and least influenced by factors other than the intervention are the primary outcome
measures to move forward to the future RCT.
Analysis plan. Reliability of the study data by instrument were determined with
Cronbach’s alpha. Significance of SĀF-T on outcome measures were evaluated with p-values by
Group, Assessment Period, and Rate of Change by group over time using constructed repeated
measures general linear mixed models.
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Objective 4
Estimate effect size of SĀF-T on primary outcome measures to calculate sample size for
the larger future study.
Success criteria 4. a) Large estimated effect size (>0.5) with 95% confidence intervals
for SĀF-T on outcome measures study day 1 (pre-SĀF-T for intervention group) and study day 3
(post-SĀF-T for intervention group) and sustained over time (study day 1 to study day 30, and
study day 1 to study day 90) are the primary outcome variable targets for the future study, b)
small to medium estimated effect size (<0.5) with 95% confidence intervals for SĀF-T on
outcome measures are possible secondary outcomes for the future RCT of SAT-T effectiveness.
Analysis plan. Means and standard deviations, effect size, and 95% confidence intervals
were determined for outcome measures by group over time.

Secondary Aim
Explore sleep in spouses during the ICU stay.

Objective 5
Test wrist actigraphy data collection on subjects during the ICU stay.
Success criteria 5. a) At least 90% of recruited subjects wore ActiWatch during the ICU
stay; and b) >90% of recruited subjects who wore the ActiWatch did not experience adverse
events (e.g., skin irritation).
Analysis plan. Descriptive statistics (means and standard deviations) for actigraphy sleep
efficiency were determined by group. Mann-Whitney U-test was used to detect differences in
actigraphy sleep efficiency by group. Agreed to wear ActiWatch and adverse events were
calculated in frequencies and percentages.

40

Study Evaluation
Evidence of the overall study outcome is evaluated with the following options:
•
•
•
•

Stop – future larger RCT of SĀF-T is not feasible;
Continue but modify protocol – larger RCT is feasible with modifications;
Continue without modifications, but monitor closely – RCT is feasible with close
monitoring; or
Continue without modifications – RCT is feasible as is.

The study flow chart (See Figure 4) presents a visual overview of the feasibility objectives paired
with study processes and includes success criteria.
Feasibility Objectives

Pilot Study Process

Objective 1
Determine enrollment rate of subjects
along with identification of any
barriers to consent for planning
timeline of future RCT

- Pre-Screen Eligibility & Exclusion Criteria
- Consent and Enroll 10 Subjects
- Randomize Group Assignment

Objective 5
Test Wrist Actigraphy Data
Collection

Objective 2
Determine SĀF-T Acceptability

Objective 3
Evaluate selection of most appropriate
primary outcome measures
Objective 4
Estimate effect size of SĀF-T

- Apply ActiWatch Study Day 1
- Collect Study Day 1 Measures
- Collect Study Day 3 Measures
- Remove ActiWatch Study Day 3

Success Criteria
1a.> 4 subjects per week can be
recruited
1b.> 50% of all eligible subjects
can be enrolled
5a.> 90% of subjects wore
ActiWatch
5b.>90% of subjects that wore
ActiWatch did not experience
adverse events

- Deliver SĀF-T to intervention group on
Study Day 1, 2 & 3

2a.> 90% of subjects randomized
to intervention group received 2 of
the 3 scheduled doses of SĀF-T
2b. >90% of subjects received
SĀF-T without adverse events

- Collect Study Day 30 Measures
- Collect Study Day 90 Measures

1c.> 60% of all recruited subjects
completed both follow-up
measures

- Data Coding
- Data Cleaning
- Data Integrity
- Data Analyses

3.Measures with highest reliability,
clinical relevance, & least
influenced by factors other than
the intervention
4. Large estimated effect size
(>0.5) with 95% confidence
intervals

Figure 4. Study flow chart with feasibility objectives and success criteria.
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CHAPTER FOUR:
RESULTS

This chapter presents the results of the study. The chapter begins with the sample,
including the flow of trial progress by group with a consort diagram, followed by a description of
the trial population with demographic characteristics and baseline clinical characteristics.

Sample
A total of 15 spouses were assessed for trial eligibility, of whom, 10 (66.7%) were
eligible and enrolled. Of the 5 subjects randomly assigned to the SĀF-T intervention (50% of the
sample), 5 (100%) received all interventions, which was1 SĀF-T intervention each day over a 3day period in the ICU environment. Of the 5 subjects assigned to the control group, 5 (100%)
received usual care each day over a 3-day period in the ICU environment. Considering both
groups, 10 of 10 subjects (100%) completed study day 1 and study day 3 assessments. Of these,
9 (90%) provided follow-up data at study day 30 and study day 90 (See Figure 5).

Demographic Characteristics
The mean age of the study sample was 57.7 ± 11.9 years, 70% were female, 70% were
White, and 30% were of Hispanic ethnicity (See Table 3). The mean distance of hospital
commute was 70.7 ± 57.3 miles. The mean level of education was 12.8 ± 1.9 years. Overall, the
two groups were well balanced on demographic characteristics except for age. The mean age for
the SĀF-T group was 64.6 ± 9.4 and 50.8 ± 10.7 for the control group. The distribution for age in
the two groups differed significantly (U=3, p<0.05).
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Excluded:
Did not meet criteria (n=4)
-Not available (4)
Unable to obtain consent (n=1)
-Declined (1)

Allocation

Enrollment

Assessed for eligibility (n=15)

Subjects enrolled and randomized to group assignment (n=10)

Group 1 - intervention
-Sensation Awareness Focused – Training (n=5)
Received all sessions of intervention in ICU and
completed study day 1 and study day 3 assessments (n=5)

Analysis

Completed follow-up at 1 month and 3 months (n=5)

Group 2 - usual care
-No Sensation Awareness Focused - Training (n=5)
Received usual care in ICU environment and completed
study day 1 and study day 3 assessments (n=5)
Completed follow-up at 1 month and 3 months (n=4)
-No response (1)

Analyzed (n=5)
Excluded from analysis (n=0)

Analyzed (n=5)
Excluded from analysis (n=0)

Figure 5. Consort diagram of trial population with enrollment, allocation, and analysis.
Table 3. Demographic Characteristics by Random Assignment
Characteristic
Race n (%):
White
Black
Ethnicity n (%):
Non-Hispanic
Hispanic
Sex n (%):
Male
Female
Age in years, mean (SD)
Distance of hospital commute in miles, mean(SD)
Level of education in years, mean (SD)

All
(n=10)

SĀF-T
(n=5)

Control
(n=5)

7 (70.0)
3 (30.0)

2 (40.0)
3 (60.0)

5 (100)
0 (00.0)

7 (70.0)
3 (30.0)

4 (80.0)
1 (20.0)

3 (60.0)
2 (40.0)

3 (30.0)
7 (70.0)
57.7 (11.94)
70.7 (57.33)
12.8 (1.93)

2 (40.0)
3 (60.0)
64.6 (09.37)
100 (68.59)
12.4 (00.89)

1 (20.0)
4 (80.0)
50.8 (10.66)
41.4 (23.31)
13.2 (02.68)

p-Value
0.17

1.0

1.0

0.05
0.08
0.72

Note: Fisher’s Exact test and Mann-Whitney U-test for distribution significance by group (p<0.05).

Baseline Measures
Baseline (study day 1, pre-SĀF-T for the intervention group) data for PICS-F measures
are presented in Table 4. The mean PSS score was 16.9 ± 4.20, 90% had a PSS score of ≥14.7,
the suggested cutpoint mean score on the norm table (Cohen, Kamarck, & Mermelstein, 1983).
In addition, 80% of the sample scored within the abnormal range (11-21) and 20% of the sample
scored within the borderline abnormal range (8-10) on the HADS anxiety subscale; while 100%
of the sample scored within the normal range (0-7) on the HADS depression subscale (Zigmond
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& Snaith, 1983). The mean IES score was 26.9 ± 6.03, 80% had a IES score > 26, the suggested
cutpoint for symptoms of PTSD (Horowitz, Wilner, & Alvarez, 1979). Additional emotional
health affect subscales of the NIH Toolbox Emotional Battery were evaluated by converting the
raw score of each measure to an uncorrected standard score (T-Score), utilizing a normative
mean of 50 (Salsman et al., 2013). At baseline, 100% of the sample fell within the T-Score range
of 40–60 on all 17 subscales. Scores more than one standard deviation (10) below the mean
(T<40) suggest “low” levels of the affect measured and scores more than one standard deviation
(10) above the mean (T>60) suggest “high” levels of the affect measured.
Overall, the two groups were balanced in the following baseline measures (study day 1,
pre-SĀF-T for the intervention group): PSS, HADS anxiety, HADS depression, PTSD, positive
affect, general life satisfaction-B, friendship, loneliness, self-efficacy, perceived stress, fear
affect, sadness, and anger physical aggression. The SĀF-T intervention group, compared to the
control group, presented with statistically significant more perceived rejection (U=0, p=0.01),
more perceived hostility (U=1, p=0.01), higher anger affect (U-0, p=0.01), and an increased
amount of anger hostility (U=2.5, p=0.02).
Lastly, compared to the control group, the SĀF-T intervention group presented at
baseline (study day 1, pre-SĀF-T for the intervention group) with statistically significant lower
amount of general life satisfaction-A (U=0.5, p=0.01), lower amount of meaning and purpose
(U=0, p=0.01), not as much emotional support (U=0.5, p=0.01), a lesser amount of instrumental
support (U=0, p=0.01), and a lower amount of fear somatic arousal (U=0, p=0.01).
Table 4. Baseline Measures by Random Assignment
Measure
PSS, mean (SD)
HADS -Anxiety, mean (SD)
HADS -Depression, mean (SD)
IES (PTSD)

All
(n=10)
16.9 (4.20)
12.6 (2.67)
4.9 (2.18)
26.9 (6.03)
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SĀF-T
(n=5)
18.2 (2.39)
13.0 (1.22)
6.2 (2.05)
30.4 (3.05)

Control
(n=5)
15.6 (5.46)
12.2 (3.77)
3.6 (1.52)
23.4 (6.47)

p-Value
0.35
0.45
0.09
0.07

Table 4 (Continued)
All
SĀF-T
Control
Measure
(n=10)
(n=5)
(n=5)
p-Value
NIH Toolbox - Emotional Battery, mean (SD)
-Positive Affect
49.9 (12.40)
47.8 (11.65)
52.0 (14.11)
0.35
-General Life Satisfaction
29.2 (7.93)
24.6 (9.40)
33.8 (0.45)
0.01
-Meaning & Purpose
30.8 (4.13)
27.6 (3.58)
34.0(0.00)
0.01
-Emotional Support
33.7 (6.80)
28.6(5.98)
38.8 (1.79)
0.01
-Instrumental Support
33.8 (6.41)
28.0 (2.74)
39.6 (0.89)
0.01
-Friendship
33.2 (5.71)
32.8 (7.73)
33.6 (3.65)
1.00
-Loneliness
7.7 (4.11)
9.0 (5.48)
6.4 (1.95)
0.64
-Perceived Rejection
13.2 (5.43)
17.0 (5.48)
9.4 (0.55)
0.01
-Perceived Hostility
11.1 (3.07)
13.0 (3.46)
9.2 (0.45)
0.01
-Self-Efficacy
30.9 (6.19)
27.4 (4.67)
34.4 (5.81)
0.07
-Perceived Stress
27.2 (3.39)
28.4 (2.30)
26.0 (5.05)
0.34
-Fear Affect
17.6 (4.79)
20.8 (1.10)
14.4 (4.98)
0.11
-Fear Somatic Arousal
9.7 (2.31)
8.8 (1.64)
10.6 (2.70)
0.01
-Sadness
13.4 (3.86)
15.0 (5.10)
11.8 (1.10)
0.50
-Anger Affect
10.9 (2.73)
13.0 (2.35)
8.8 (0.45)
0.01
-Anger Hostility
6.8 (2.94)
8.6 (3.36)
5.0 (0.00)
0.02
-Anger Physical Aggression
8.3 (2.21)
8.8 (3.03)
7.8 (1.10)
1.00
Note: Mann-Whitney U-test to determine distribution significance by group (p<0.05). PSS (Perceived
Stress Scale), HADS (Hospital Anxiety & Depression Scale), IES (Impact of Event Scale).

Primary Aim
Assess feasibility and estimate effect size of the 3-day SĀF-T intervention on PICS-F
(symptoms of stress, anxiety, depression, and PTSD) for spouses of mechanically ventilated
patients admitted to the ICU who are acting as the surrogate decision-maker for the patient.

Objective 1
Determine enrollment rate of subjects along with identification of any barriers to consent
for planning timeline of future RCT.
Success Criteria 1. a) 4 subjects per week can be recruited; b) at least 50% of all eligible
subjects can be enrolled; and c) at least 60% of all recruited subjects completed follow-up
measures.
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The mean weekly recruitment of subjects was 7.5, which is well above the success
criteria of 4 subjects per week. The mean enrollment rate was 67%, exceeding the success
criteria of a minimum 50% enrollment rate (See Figure 6). All 10 (100%) subjects completed
study day 1 (pretest) and study day 3 (posttest) assessments during the ICU stay, and 9 (90%)
subjects completed the follow-up measures at study day 30 and study day 90 (See Figure 7). The
success criteria of at least 60% completed measures rate was achieved.

Subjects

20

70%

15
10

7

60%

10

100%

15

67%
10

3

5

50%

5

0

0%
Week of 9/3/17

Week of 9/10/17

Enrollments

Screened

TOTALS
Subject Enrollment Rate %

Figure 6. Weekly recruitment and subject enrollment rate meet feasibility success criteria.
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50%

1

0%
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Subjects Enrolled

Day 3 Posttest

Day 30 Follow-up

Subjects that Completed Measures

Day 90 Follow-up
Completed Measures Rate %

Figure 7. Outcome measures completion rate meet feasibility success criteria.

Objective 2
Determine acceptability of providing SĀF-T to subjects during the ICU stay.
Success Criteria 2. a) At least 90% of recruited subjects randomized to intervention
group received 2 of the 3 scheduled doses of SĀF-T in the ICU; and b) >90% of subjects
received SĀF-T without adverse events (e.g., increased stress on post-SĀF-T assessment).
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Among the 5 recruited subjects randomized to receive SĀF-T, 5 (100%) underwent all 3
sessions, for a total of 15 (100%) sessions, which exceeds the success criteria. The mean
individual SĀF-T session time was 12.3 + 1.05 minutes. The combined total mean SĀF-T
session time was 37 + 3.16 minutes (See Table 5). The pre SĀF-T stress mean visual analog
score was 6.3 + 1.29 and the post SĀF-T stress mean visual analog score was 3.8 + 0.56 with a
mean difference of 2.53 + 0.36. A Wilcoxon-Signed Rank Test indicated the post SĀF-T stress
visual analog scores were statistically significantly lower than the pre SĀF-T stress visual analog
scores (Z = -3.47, p=0.01). There were no adverse events reported (See Figure 8). The SĀF-T
intervention met all acceptability criteria.
Table 5. Descriptive Statistics for Sensation Awareness Focused Training (SĀF-T) Intervention
Stress Visual Analog Scale
Score Range 1-10 (n=15)
SĀF-T
Group (n=5)
1
2
3
4
5
Overall
mean, (SD)

Number of
SĀF-T
Sessions
3
3
3
3
3

Combined SĀF-T
Sessions Total
Time (minutes)
32.0
36.0
40.0
38.0
39.0

Daily SĀF-T
Session Time
Mean (SD)
10.7 (1.15)
12.0 (2.00)
13.3 (2.89)
12.7 (1.15)
13.0 (2.65)

Pre SĀF-T
Mean (SD)
5.3 (0.58)
6.0 (1.00)
7.3 (2.08)
6.3 (0.58)
6.7 (1.53)

Post SĀF-T
Mean (SD)
3.3 (0.58)
4.0 (0.00)
4.0 (1.00)
4.0 (0.00)
3.7 (0.58)

Change in
Pre-SĀF-T & Post
SĀF-T Stress Scores
2.00
2.00
3.33
2.33
3.00

3 (0)

37.0 (3.16)

12.3 (1.05)

6.3 (1.29)

3.8 (0.56)

p=0.01

Note: Wilcoxon Signed Rank Test for significance in change of pre-SĀF-T/post-SĀF-T scores (p<0.05).
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Figure 8. SĀF-T (Sensation Awareness Focused Training) intervention was acceptable.
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Objective 3
Evaluate selection of most appropriate primary outcome measures.
Success Criteria 3. Measures with highest reliability (Cronbach’s alpha), more clinical
relevance, and least influenced by factors other than the intervention are the primary outcome
measures to move forward to the future RCT.
Cronbach’s alpha for the study with the Perceived Stress Scale (.65) and NIH Toolbox
Emotional Battery subscale perceived stress (.66) suggests approximately equivalent reliability
(See Table 6). To include both measures for the larger study may add unnecessary subject burden
and data redundancy. The comparison of Cronbach’s alpha for the HADS subscale anxiety (.61)
and NIH Toolbox Emotional Battery subscale fear affect (.78) suggests greater reliability in the
study using the NIH Toolbox. Cronbach’s alpha for data collected in the study using the HADS
subscale depression (.16) was not reliable. Depression is captured in the NIH Toolbox Emotional
Battery with the subscale sadness and Cronbach’s alpha (.90) suggests this data collected during
the study has high reliability. Comparison of Cronbach’s alpha for IES (.57) symptoms of PTSD
and the NIH Toolbox Emotional Battery subscales fear affect (.78), fear somatic arousal (.53),
sadness (.90), anger affect (.79), anger hostility (.90), anger physical aggression (.78), perceived
stress (.66), and self-efficacy (.94) suggest higher reliability in the data collected during the study
using the NIH Toolbox.
The NIH Toolbox Emotional Battery is made up of four subdomains (Negative Affect,
Psychological Well-Being, Stress and Self-Efficacy, and Social Relationships) that are clinically
relevant to health outcomes. The PSS and HADS instruments did not demonstrate added clinical
relevance to be recommended for inclusion in the larger study. However, an instrument, other
than the IES (due to study Cronbach’s alpha <.70), that is specific to assess symptoms of PTSD
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in the main study is needed. This is the first study to utilize SĀF-T as an intervention for PICS-F.
Mediators and moderators that effect SĀF-T are not known. The broadness of measurements in
the NIH Toolbox Emotional Battery is advantageous with a wide variety of common metrics for
use in the main study.
Table 6. Reliability of Study Outcome Measures (n=38)
Outcome Measure
-Symptoms of Stress
-Symptoms of Anxiety
-Symptoms of Depression
-Symptoms of PTSD
-Positive Affect
-General Life Satisfaction
-Meaning & Purpose
-Emotional Support
-Instrumental Support
-Friendship
-Loneliness
-Loneliness
-Perceived Rejection
-Perceived Hostility
-Self-Efficacy
-Perceived Stress
-Fear Affect
-Fear Somatic Arousal
-Sadness
-Anger Affect
-Anger Hostility
-Anger Physical Aggression

Instrument
Perceived Stress Scale (PSS)
Hospital Anxiety and Depression Scale
(HADS)
Impact Event Scale (IES)
NIH Toolbox Emotional Battery

Cronbach’s Alpha
.65
.61
.16
.57
.95
.97
.93
.97
.98
.92
.97
.97
.96
.87
.94
.66
.78
.53
.90
.79
.90
.78

Among the 5 subjects randomly assigned to SĀF-T compared to the control group, the
mean scores were statistically significant in general life satisfaction (p=0.04), meaning and
purpose (p=0.01), emotional support (p=0.01), perceived rejection (p=0.03), self-efficacy
(p=0.01), fear affect (p=0.01), fear somatic arousal (p=0.01), sadness (p=0.01), and anger affect
(p=0.01). The change in mean scores by assessment period were statistically significant in PSS
(p=0.01), HADS anxiety (p=0.04), IES PTSD (p=0.01), meaning and purpose (p=0.01),
emotional support (p=0.01), self-efficacy (p=0.01), and perceived stress (p=0.01). The rate of

49

change in scores between the SĀF-T group and control group were statistically significant in
PSS (p=0.01), IES PTSD (p=0.03), general life satisfaction (p=0.01), perceived rejection
(p=0.01), self-efficacy (p=0.01), perceived stress (p=0.02), fear affect (p=0.03), fear somatic
arousal (p=0.01), and sadness (p=0.03).
There was insufficient data variability in the sample for the mixed model to converge in
the outcome variables depression, instrumental support, friendship, loneliness, perceived
hostility, anger hostility, and anger physical aggression.
Table 7. Repeated Measures Mixed Model on Outcome Measures
Outcome Measure
Perceived Stress Scale
-Anxiety
Impact of Event Scale (PTSD)
-Positive Affect
-General Life Satisfaction
-Meaning & Purpose
-Emotional Support
-Perceived Rejection
-Self-Efficacy
-Perceived Stress
-Fear Affect
-Fear Somatic Arousal
-Sadness
-Anger Affect
.

n
38
38
38
38
38
38
38
38
38
38
38
38
38
38

Group
p-Value
0.21
0.42
0.28
0.53
0.04
0.01
0.01
0.03
0.01
0.65
0.01
0.01
0.01
0.01

Assessment Period
p-Value
0.01
0.04
0.01
0.15
0.54
0.01
0.01
0.26
0.01
0.01
0.75
0.13
0.75
0.08

Rate of Change
p-Value
0.01
0.06
0.03
0.33
0.01
0.16
0.06
0.01
0.01
0.02
0.03
0.01
0.03
0.98

The following Figures 9-17 illustrate a comparison of slopes by group over time with
significant differences in rate of change (p<0.05). At study day 1, subjects randomly assigned to
SĀF-T perceived more stress than the control group. Mean scores within each group
significantly changed over time (p=0.01). Perceived stress increased during the ICU stay for the
control group and decreased in the group that received SĀF-T each day for 3-days in the ICU.
The rate of change in the PSS and NIH Toolbox Emotion Battery subscale perceived stress (a
comparison of the slopes between the SĀF-T group and control group over time) were
statistically significant (PSS, p=0.01; perceived stress, p=0.02) (See Figures 9 & 10).
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Mean
Score

SAF-T

Control

PSS p=0.01

20
18.2

19

18.4

18
17
16
15

15.5

15.25

15.6
15

14

13.8

13

13

12
11
10

Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 9. Rate of change in Perceived Stress Scale was statistically significant in repeated
measures mixed model.

SAF-T

Mean
Score

30
29
28
27
26
25
24
23
22

28.4

Control

Perceived Stress p=0.02

28.4

26

26
25

25
23.8
23

Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 10. Rate of change in NIH Toolbox Emotional Battery subscale perceived stress was
statistically significant in repeated measures mixed model.

At study day 1, subjects randomly assigned to the control group had significantly more
self-efficacy than subjects assigned to the SĀF-T group (p=0.01). Mean scores within each group
significantly changed over time (p=0.01). Self-efficacy decreased during the ICU stay for the
control group and gradually increased over time in the SĀF-T group. The rate of change in selfefficacy (a comparison of the slopes between the SĀF-T group and control group over time), was
statistically significant (p=0.01) (See Figure 11).
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34

33

32

31

33.3
31.4

31.8

30
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Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 11. Rate of change in NIH Toolbox Emotional Battery subscale self-efficacy was
statistically significant in repeated measures mixed model.
At study day 1, subjects randomly assigned to the SĀF-T group had more symptoms of
PTSD than subjects randomly assigned to the control group (See Figure 12). Symptoms of PTSD
within each group significantly changed over time (p=0.01). Symptoms of PTSD continuously
decreased over time for the SĀF-T group. In the control group, symptoms of PTSD increased
during the ICU stay, decreased at study day 30, and increased again at study day 90. The rate of
change in symptoms of PTSD (a comparison of the slopes between the SĀF-T group and control
group over time), was statistically significant (p=0.03).
Mean
Score

SAF-T

PTSD p=0.03

Control

35
30.4
30
25

27.2
23.25
23.4

20.75

23.6
20

19.8

18

15

Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 12. Rate of change in Impact of Event Scale (PTSD) was statistically significant in
repeated measures mixed model.
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At study day 1 and across all time points, subjects randomly assigned to SĀF-T liked
their lives significantly more than the control group (p=0.04). The mean scores within each
group remained consistent and did not significantly change over time. In Figure 13, the rate of
change (a comparison of the slopes between the SĀF-T group and control group over time) was
statistically significant (p=0.01).
Mean
Score

SAF-T

40
30

Control

General Life Satisfaction p=0.01

33.8

33.2

33.3

33.3

24.6

24.6

24.6

24.8

Study Day 3

Study Day 30

20

Study Day 1

Study Day 90

Figure 13. Rate of change in NIH Toolbox Emotional Battery subscale general life satisfaction
was statistically significant in repeated measures mixed model.
At study day 1, subjects randomly assigned to SĀF-T perceived significantly more
rejection than the control group (p=0.03). Over time, mean perceived rejection scores within the
SĀF-T group were trending downward. The mean perceived rejection scores for the control
group were trending upward during the ICU stay and over time at study day 30 and began
trending downward at study day 90 (See Figure 14). The rate of change (a comparison of the
slopes between the SĀF-T group and control group over time), was statistically significant
(p=0.01).
Mean
Score

18

SAF-T
17

13
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Perceived Rejection p=0.01

17

16.8

10.2

10.9
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10
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Study Day 1
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Figure 14. Rate of change in NIH Toolbox Emotional Battery subscale perceived rejection was
statistically significant in repeated measures mixed model.
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At study day 1, subjects randomly assigned to SĀF-T had significantly more feelings of
fearfulness than the control group (p=0.01). Fear affect continuously decreased over time in the
SĀF-T group. Fear affect increased during the ICU stay in the control group and decreased at
study day 30. The mean scores within each group did not significantly change over time. In
Figure 15, the rate of change (a comparison of the slopes between the SĀF-T group and control
group over time), was statistically significant (p=0.03).
Mean
Score
22

SAF-T
20.8
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19.6
17.2

17

14.4

Fear Affect p=0.03

17

18
16

16

12

Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 15. Rate of change in NIH Toolbox Emotional Battery subscale fear affect was
statistically significant in repeated measures mixed model.
At study day 1, subjects randomly assigned to SĀF-T had significantly less somatic
arousal than the control group (p=0.01). Somatic arousal continuously decreased over time in the
SĀF-T group. In the control group, somatic arousal increased during the ICU stay and decreased
over time at study day 30 and study day 90. The mean scores within each group did not
significantly change over time. In Figure 16, the rate of change (a comparison of the slopes
between the SĀF-T group and control group over time), was statistically significant (p=0.01).
Mean
Score

SAF-T

13
11
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11

8.8
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9
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Fear Somatic Arousal p=0.01

10
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9.3
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7

Study Day 1

Study Day 3

Study Day 30

Study Day 90

Figure 16. Rate of change in NIH Toolbox Emotional Battery subscale fear somatic arousal was
statistically significant in repeated measures mixed model.
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At study day 1, subjects randomly assigned to SĀF-T were significantly sadder than the
control group (p=0.01). Sadness continuously decreased over time in the SĀF-T group. Sadness
increased during the ICU stay in the control group, decreased at study day 30, and returned to
baseline at study day 90. The mean scores within each group did not significantly change over
time. In Figure 17, the rate of change (a comparison of the slopes between the SĀF-T group and
control group over time), was statistically significant (p=0.03).
Mean
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16
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12
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11

Study Day 1

Study Day 3
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Figure 17. Rate of change in NIH Toolbox Emotional Battery subscale sadness was statistically
significant in repeated measures mixed model.

Objective 4
Estimate effect size of SĀF-T on primary outcome measures to calculate sample size for
the larger future study.
Success criteria 4. a) Large estimated effect size (>0.5) with 95% confidence intervals
for SĀF-T on outcome measures study day 1 (pre-SĀF-T in intervention group) and study day 3
(post-SĀF-T for intervention group) and sustained over time (study day 1 to study day 30, and
study day 1 to study day 90) are the primary outcome variable targets for the future study, b)
small to medium estimated effect size (<0.5) with 95% confidence intervals for SĀF-T on
outcome measures are possible secondary outcomes for a future RCT of SAT-T effectiveness.
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The 5 (100%) subjects assigned to SĀF-T completed all 3 sessions (per study protocol).
Large estimated effect size among the 5 randomly assigned to SĀF-T compared to the 5
randomly assigned to the control group occurred in the mean study day 1 (pre-SĀF-T for the
intervention group) to study day 3 (post-SĀF-T for the intervention group) change in the
following outcome measures: fear affect, perceived hostility, PTSD, anxiety, PSS, perceived
stress, anger affect, self-efficacy, positive affect, and general life satisfaction (See Table 7). Due
to the large estimated effect size, they will serve as primary outcome variable targets for the
future RCT.
Table 8. Estimated Effect Size of SĀF-T on Outcome Measures – Study Day 1 to Study Day 3
SĀF-T Group
Outcome Measure
Perceived Stress
Hospital Anxiety and Depression Scale
-Anxiety
-Depression
Impact of Event (PTSD)
NIH Toolbox Emotional Battery
-Positive Affect
-General Life Satisfaction
-Meaning & Purpose
-Emotional Support
-Instrumental Support
-Friendship
-Loneliness
-Perceived Rejection
-Perceived Hostility
-Self-Efficacy
-Perceived Stress
-Fear Affect
-Fear Somatic Arousal
-Sadness
-Anger Affect
-Anger Hostility
-Anger Physical Aggression

Control Group
Diff

Effect
Size

Day 1

Day 3

Diff

Day 1

Day 3

18.2

15.0

-3.2

15.6

18.4

2.8

1.51

0.15 – 2.87

95% CI

13.0
6.2
30.4

10.0
6.2
23.6

-3.0
0
-6.8

12.2
3.6
23.4

13.8
4.2
27.3

1.6
0.6
3.9

1.58
0.15
1.94

0.20 – 2.96
-1.00 – 1.30
0.45 – 3.42

47.8
24.6
27.6
28.6
28.0
32.8
9.0
17.0
13.0
27.4
28.4
20.8
8.8
15.0
13.0
8.6
8.8

55.8
24.6
27.4
29.2
28.0
32.8
9.0
17.0
13.0
31.0
25.0
18.0
8.6
14.2
11.4
8.6
8.8

-8.0
0.0
0.2
-0.6
0.0
0.0
0.0
0.0
0.0
-3.6
3.4
2.8
0.2
0.8
1.6
0.0
0.0

52.0
33.8
34.0
38.8
39.6
33.6
6.4
9.4
9.2
34.4
26.0
14.4
10.6
11.8
8.8
5.0
7.8

50.2
33.2
33.0
38.8
38.0
33.6
7.8
10.2
15.0
33.0
28.4
19.6
11.0
12.6
9.4
5.0
6.8

1.8
0.6
1.0
0.0
1.6
0.0
-1.4
-0.8
-5.8
1.4
-2.4
-5.2
-0.4
-0.8
-0.6
0.0
1.0

-0.73
-0.64
-0.16
-0.21
-0.49
0.00
0.32
0.19
2.06
-1.03
1.50
2.16
0.28
0.45
1.28
0.00
-0.45

-1.92 – 0.47
-1.82 – 0.55
-1.30 – 0.99
-1.36 – 0.94
-1.66 – 0.68
-1.14 – 1.14
-0.84 – 1.47
-0.96 – 1.33
0.53 – 3.58
-2.28 – 0.22
0.14 – 2.87
0.60 – 3.71
-0.87 – 1.44
-0.71 – 1.61
-0.03 – 2.58
-1.14 – 1.14
-1.61 – 0.72

Of the 10 subjects who completed pretest/posttest assessments, 9 (90%) provided followup data at study day 30. Among these 9 subjects, 5 were in the SĀF-T group and 4 were in the
control group. Large estimated effect size among the 5 randomly assigned to SĀF-T, compared
to the control group, occurred in the mean study day 1 to study day 30 change in the following
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outcome measures: perceived hostility, PTSD, instrumental support, fear somatic arousal,
perceived stress, anger affect, PSS, anxiety, self-efficacy, fear affect, sadness, positive affect, and
general life satisfaction (See Table 8). Due to the large estimated effect size, they will serve as
primary outcome variable targets for the future RCT.
Table 9. Estimated Effect Size of SĀF-T on Outcome Measures – Study Day 1 to Study Day 30
SĀF-T Group
Outcome Measure
Day 1
Perceived Stress Scale
18.2
Hospital Anxiety and Depression Scale
-Anxiety
13.0
-Depression
6.2
Impact of Event Scale (PTSD)
30.4
NIH Toolbox Emotional Battery
-Positive Affect
47.8
-General Life Satisfaction
18.4
-Meaning & Purpose
27.6
-Emotional Support
28.6
-Instrumental Support
28.0
-Friendship
32.8
-Loneliness
9.0
-Perceived Rejection
17.0
-Perceived Hostility
13.0
-Self-Efficacy
27.4
-Perceived Stress
28.4
-Fear Affect
20.8
-Fear Somatic Arousal
8.8
-Sadness
15.0
-Anger Affect
13.0
-Anger Hostility
8.6
-Anger Physical Aggression
8.8

Control Group
Effect
Size

Day 30

Diff

Day 1

Day 30

Diff

13.8

-4.4

15.6

15.5

-0.1

1.13

-0.14 – 2.40

95% CI

9.4
5.0
19.8

-3.6
-1.2
-10.6

12.2
3.6
23.4

10.0
3.5
20.8

-2.2
-0.1
-2.6

0.95
0.47
1.39

-0.28 – 2.19
-0.70 – 1.64
0.06 – 2.72

58.6
18.8
27.2
29.8
28.3
32.8
9.0
16.8
13.0
31.4
23.8
17.2
7.8
12.8
11.2
8.6
8.8

-10.8
-0.4
0.4
-1.2
-0.3
0.0
0.0
0.2
0.0
-4.0
4.6
3.6
1.0
2.2
1.8
0.0
0.0

52.0
22.0
34.0
38.8
39.6
33.6
6.4
9.4
9.2
34.4
26.0
14.4
10.6
11.8
8.8
5.0
7.8

55.3
21.0
32.5
39.0
37.3
30.8
5.0
10.9
14.8
33.3
26.0
16.0
10.0
12.0
8.8
5.0
6.8

-3.3
1.0
1.5
-0.2
2.3
2.8
1.4
-1.5
-5.6
1.1
0.0
-1.6
0.6
-0.2
0.0
0.0
1.0

-0.57
-0.52
-0.03
-0.47
-1.31
-0.44
-0.30
0.35
1.93
-0.90
1.23
0.81
1.30
0.63
1.14
0.09
-0.41

-1.81 – 0.67
-1.75 – 0.71
-1.24 – 1.17
-1.70 – 0.75
-2.69 – 0.08
-1.66 – 0.78
-1.52 – 0.91
-0.87 – 1.56
0.36 – 3.50
-2.19 – 0.39
-0.13 – 2.59
-0.46 – 2.09
-0.08 – 2.68
-0.62 – 1.88
-0.20 – 2.48
-1.11 – 1.29
-1.63 – 0.81

Of the 10 subjects who completed study day 1 and study day 3 assessments, 9 (90%)
provided follow-up data at study day 90. Among the 9 subjects, 5 were in the SĀF-T group and 4
were in the control group. Large estimated effect size among the 5 randomly assigned to SĀF-T
compared to the control group occurred in the mean study day 1 to study day 90 change in the
following outcome measures: PTSD, perceived hostility, anger affect, instrumental support,
PSS, perceived stress, fear affect, anxiety, self-efficacy, fear somatic arousal, sadness, positive
affect, and general life satisfaction (See Table 9). Due to the large estimated effect size, they will
serve as primary outcome variable targets for the future RCT.
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Table 10. Estimated Effect Size of SĀF-T on Outcome Measures - Study Day 1 to Study Day 90
SĀF-T Group
Outcome Measure
Day 1
Perceived Stress Scale
18.2
Hospital Anxiety and Depression Scale
-Anxiety
13.0
-Depression
6.2
Impact of Event Scale (PTSD)
30.4
NIH Toolbox Emotional Battery
-Positive Affect
47.8
-General Life Satisfaction
18.4
-Meaning & Purpose
27.6
-Emotional Support
28.6
-Instrumental Support
28.0
-Friendship
32.8
-Loneliness
9.0
-Perceived Rejection
17.0
-Perceived Hostility
13.0
-Self-Efficacy
27.4
-Perceived Stress
28.4
-Fear Affect
20.8
-Fear Somatic Arousal
8.8
-Sadness
15.0
-Anger Affect
13.0
-Anger Hostility
8.6
-Anger Physical Aggression
8.8

Control Group

Day 90

Diff

Day 1

Day 90

Diff

Effect
Size

13.0

-5.2

15.6

15.3

-0.3

1.26

-0.04 – 2.56

9.2
5.0
18.0

-3.8
-1.2
-12.4

12.2
3.6
23.4

10.0
3.5
23.3

-2.2
-0.1
-0.1

0.97
0.47
1.95

-0.27 – 2.21
-0.70 – 1.64
0.46 – 3.45

59.2
18.8
27.2
30.0
28.2
32.8
9.0
16.6
13.0
31.8
23.0
17.0
7.8
12.8
11.0
8.6
8.8

-11.4
-0.4
0.4
-1.4
-0.2
0.0
0.0
0.4
0.0
-4.4
5.4
3.8
1.0
2.2
2.0
0.0
0.0

52.0
22.0
34.0
38.8
39.6
33.6
6.4
9.4
9.2
34.4
26.0
14.4
10.6
11.8
8.8
5.0
7.8

56.3
21.0
33.0
39.0
37.3
30.8
5.0
10.0
14.8
33.3
25.0
16.0
9.3
11.8
8.8
5.0
6.8

-4.3
1.0
1.0
-0.2
2.3
2.8
1.4
-0.6
-5.6
1.1
1.0
-1.6
1.3
0.0
0.0
0.0
1.0

-0.54
-0.52
0.22
-0.45
-1.31
-0.44
-0.30
0.41
1.93
-0.96
1.13
1.02
0.75
0.58
1.35
0.09
-0.41

-1.78 – 0.69
-1.75 – 0.71
-0.99 – 1.43
-1.68 – 0.77
-2.69 – 0.08
-1.66 – 0.78
-1.52 – 0.91
-0.81 – 1.63
0.36 – 3.50
-2.26 – 0.35
-0.21 – 2.47
-0.30 – 2.33
-0.52 – 2.01
-0.66 – 1.82
-0.05 – 2.74
-1.11 – 1.29
-1.63 – 0.81

95% CI

Secondary Aim
Explore sleep in spouses during the ICU stay.

Objective 5
Test wrist actigraphy data collection on subjects during the ICU stay.
Success Criteria 5. a) At least 90% of recruited subjects wore ActiWatch during the ICU
stay; and b) >90% of recruited subjects who wore the ActiWatch did not experience adverse
events (e.g., skin irritation).
Among the 10 recruited subjects, 9 (90%) agreed to wear the ActiWatch and of these 9
(100%) did not experience any adverse events from wearing the ActiWatch, which meets the
success criteria for ActiWatch acceptance (See Figure 18).
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Figure 18. ActiWatch was acceptable and feasible to explore sleep during the ICU stay.

The mean sleep efficiency percentage among the 5 subjects randomly assigned to the
SĀF-T group was 70.4 + 15.24 and among the 4 subjects in the control group was 64 + 20.59
(See Table 11). A Mann-Whitney U-test suggests the difference of 6.4 + 4.52 in sleep efficiency
percentage between groups was not statistically significant (U=9, p=0.81).
Table 11. Descriptive Statistics for Actigraphy Sleep Efficiency % by Group
Variable
n
Mean
SD
Minimum
Maximum
Adverse Events
Group
-SĀF-T Group
5
70.4
15.24
54.0
88.0
0
-Control Group
4
64.0
20.59
40.0
90.0
0
Note: Mann-Whitney U-test for distribution significance by group (p<0.05).
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p-Value
0.81

CHAPTER FIVE:
DISCUSSION

The final chapter of this dissertation begins with a summary of the study findings,
implications for the main study, and study outcome evaluation. This chapter includes strengths
and limitations of the study. Lastly, conclusions of the study are discussed.

Study Findings
The study findings support the primary aim to assess feasibility and estimate effect size
of the 3-day SĀF-T intervention on PICS-F (symptoms of stress, anxiety, depression, and PTSD)
for spouses of mechanically ventilated patients admitted to the ICU, who are acting as the
surrogate decision-maker for the patient; and the secondary aim to explore sleep in spouses
during the ICU stay. In this first randomized controlled trial of SĀF-T with a central focus on
PICS-F, recruitment and enrollment rates of subjects in the study exceeded the success criteria.
Planning the timeline of the larger future study can be completed with a high level of confidence
using two subjects per week or eight subjects per month as target enrollment goals. Among those
enrolled, it is feasible that approximately 4.8 (60%) subjects per month will complete all
repeated outcome measures. Wearing the ActiWatch and administration of SĀF-T during the
ICU stay appears to be safe, acceptable, and feasible for subjects. Since the decrease in stress
scores following SĀF-T were significant (p<.05), it is important in the future study to control
subject interaction and incidental sharing of intervention effects, which could have a negative
impact in internal validity. Table 12 presents the outcome measures with high reliability
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(Cronbach’s alpha >.70), large estimated effect size (>.50), and significant rate of change (p<.05)
that will serve as primary outcome measures for PICS-F in a future larger RCT to evaluate
effectiveness of the intervention.
Table 12. Primary Outcome Measures for PICS-F in Future RCT
Outcome Variable
Self-efficacy
General Life Satisfaction
Perceived Rejection
Fear Somatic Arousal
Perceived Stress
PTSD
Fear Affect
Sadness
Positive Affect
Anger Affect
Perceived Hostility
Instrumental Support

Cronbach's
Alpha
0.94
0.97
0.96
0.53
0.66
0.57
0.78
0.90
0.95
0.79
0.87
0.98

Study Day 1 to
Study Day 3
Effect Size
-1.03
-0.73
0.19
0.28
1.50
1.94
2.16
0.45
-0.73
1.28
2.06
-0.49

Study Day 1 to Study Day 1 to
Study Day 30 Study Day 90
Effect Size
Effect Size
-0.90
-0.96
-0.52
-0.52
0.35
0.41
1.30
0.75
1.23
1.13
1.39
1.95
0.81
1.02
0.63
0.58
-0.57
-0.54
1.14
1.35
1.93
1.93
-1.31
-1.31

Rate of
Change
0.01
0.01
0.01
0.01
0.02
0.03
0.03
0.03
0.33
0.98
IDV
IDV

Note: IDV (insufficient data variability) for mixed model.
Similar patterns in the rate of change occurred by group in outcome measures perceived
stress, PTSD, fear affect, fear somatic arousal, perceived rejection, and sadness. During the ICU
stay, these conditions increased or became worse in the control group and decreased or improved
in the SĀF-T group. Consistent with the literature (Salsman et al., 2013), self-efficacy and life
satisfaction decreased in the control group as their stress, fear, rejection, and sadness increased.
Self-efficacy and life satisfaction in the SĀF-T group increased as their stress, fear, rejection,
and sadness decreased.
Due to small effect size, the outcome measures friendship, loneliness, anger hostility, and
anger physical aggression will serve as secondary outcome measures in the larger RCT. The PSS
is incorporated in the NIH Toolbox Emotion Battery subscale perceived stress. Since Cronbach’s
alpha was approximately equivalent in study data collected with both instruments, the PSS is
redundant will not be used in the larger effectiveness trial. For similar reasons, data collected
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during the study using the NIH Toolbox Emotion Battery subscales fear affect and sadness
compared with study data collected with HADS appear to be approximately equivalent or
superior in reliability. Thus, HADS will not be used in the larger effectiveness trial. The
reliability of data collected during the study using the IES for symptoms of PTSD was low
(Cronbach’s alpha <.70) and did not demonstrate confidence for use in the larger RCT. Evidence
in the literature suggest PTSD is the most prevalent condition of PICS-F. Although the NIH
Toolbox Emotion Battery has several subscales comparable with symptoms of PTSD (i.e., fear
affect, fear somatic arousal, sadness, anger affect, anger hostility, anger physical aggression,
perceived stress, and self-efficacy), an additional instrument specific to symptoms of PTSD with
sound psychometric properties is recommended for future studies of SĀF-T. Additional areas of
measurement to consider for future studies that could be advantageous and are common metrics
for the 2017 Family-Centered Care Guidelines include: Family Quality of Life, Family Quality
of Dying, Family Burden, and Family Decisional Regret (Davidson et al., 2017).

Study Outcome
Collectively, these findings suggest evidence of SĀF-T feasibility with modifications to
protocol outcome measures. The preliminary analyses indicate that additional research about the
effectiveness of SĀF-T in reducing PICS-F are warranted. A large effect size can be used in the
a priori power analysis to calculate the sample size for the future RCT.

Study Strengths and Limitations
Strengths of the study include use of a highly standardized treatment protocol (SĀF-T);
randomized controlled trial design; and clear feasibility aims, objectives, and success criteria.
Small sample size is both a strength and limitation for the study. The strength of the small
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sample size is it allows for optimal focus on feasibility of the study. Limitations of a small
sample size include insufficient power to examine all relationships between variables and detect
all significant effects (although it is noted that this was not an aim of the study), and inability to
assure normal distributions. There are limitations within the use of self-report measures, which
can exhibit problems with honesty, introspective ability, accurate understanding, use of rating
scales, and response bias. Lastly, a limitation of the pilot study was lack of blinding to the
intervention for the research staff. For this reason, unblinded data collected during the pilot study
will not be combined with blinded data collected during any future studies.

Conclusions
PICS-F is an emerging, growing problem. Our disproportionately larger aging population
is at higher risk for critical care due to age-related trauma and illness. Thus, a growing number of
family members will be at the bedside of their aging loved ones and exposed to critical care. Due
to advancements in science and technology, the rate of ICU survivorship is increasing, which
means an increasing number of family members will become informal caregivers throughout the
long recovery process of the ICU survivor. Evidence of feasibility in this small study
demonstrates it is possible to redesign critical care to include both patient and their family as a
unit in need of care for the best possible outcomes. There is enormous opportunity to work
smarter in the delivery of critical care to prevent both PICS and PICS-F. The rigor of randomized
controlled trials (RCT) for effective preventative interventions is warranted. Well-designed
preliminary studies with clear feasibility aims, objectives, and success criteria are an essential
prerequisite to enhance the likelihood of success for full-scale RCT main studies.
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